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Abstract 
Sinorhizobium meliloti belongs to nitrogen-fixing Rhizobia, the members of the 
Rhizobiales order of the α-proteobacteria. It can establish a symbiotic relationship with the 
Leguminosae family of flowering plants. It is also able to accumulate poly(3-hydroxybutyrate) 
(P(3HB)) naturally in the presence of excess carbon source. Its genome sequence, has been fully 
annotated and well-defined. In spite of its important applications in agriculture, its potential 
applications in industry have not been paid much attention. We aimed to develop this strain as a 
robust platform for the production of novel bioplastics which can eventually replace persistent 
fossil-fuel plastics.  
Two engineered genes including pct, encoding propionate CoA transferase and phaC, 
encoding PhaC synthase, were partially codon-optimized in S. meliloti. Subsequently they were 
introduced into the strains by either being integrated into the chromosome or being placed on an 
expression plasmid. The integrant strain which has engineered genes expressed under the native 
promoter is able to produce P(3HB-co-LA) up to 15% dry cell weight (DCW) constituting 30% 
mol lactic acid (LA). When genes were put in the expression plasmid and expressed under the 
inducible promoter, phenotype complementation was observed in the phaC mutant strain. 
However, only P(3HB) was able to be produced using this system. We also observed the adverse 
effects of the induction on polymer production. The higher the induction, the more enzyme 
activity of reporter gene was detected, but the less amount of P(3HB) was produced.  
S. meliloti is a native short chain length (SCL) polyhydroxyalkanoate (PHA) producer, 
while P. putida is a native medium chain length (MCL) PHA producer. Unlike S. meliloti which 
has not been well-studied for non-P(3HB) polymer production, P. putida has been drawn a great 
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deal of attention to be engineered for the production of various types of polymer. Therefore, we 
would like to discover our plasmid-based system in this strain. The results are very promising 
since it is, to our knowledge, the first time the P(LA-co-3HB-co-3HHx-co-3HO) has been 
discovered to be produced in bacterial cells.  
 Promoter engineering is also a critical strategy in metabolic engineering. A range of 
promoters of different strengths, which have been well-studied, were selected. The results are 
very interesting because the relative activities were changed in the presence of synthesized 
genes. The recovery of promoter strengths in the absence of synthesized genes indicated that the 
promoter strengths depend on genetic context. Analysis of transcript abundance was consistent 
with the gusA reporter gene measurements.  
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Claims of Contribution to Scientific Knowledge 
 This is the first attempt to engineer Sinorhizobium meliloti and Pseudomonas putida for 
novel polymer production by optimizing and introducing two previously engineered 
genes, pct encoding propionate CoA transferase from Clostridium propionicum DSM 
1682  and phaC encoding PhaC synthase from Pseudomonas sp. MBEL 6-19 
 Chromosome-engineered S. meliloti strain designated as SmUW254 was constructed. 
SmUW254 showed phenotypic complementation described as mucoid and white color. 
The strain also exhibited fluorescence when growing on YEM media supplemented with 
mannitol and Nile Red. The result indicates that the chromosome-engineering system is 
functional in the strain. 
 P(3HB-co-LA) copolymer was produced in chromosome-engineered strain SmUW254 up 
to 15% DCW with 30% mol LA. This is the first time S. meliloti produces this type of 
polymer. 
 Purification of P(3HB-co-LA) copolymer was performed so that the structure of P(3HB-
co-LA) was able to be confirmed by NMR and GC/MS. The result is consistent with the 
result from GC-FID. 
 Expression vector pTAM which contains these aforementioned genes was constructed 
from pTH1227. The pTAM plasmid was then introduced into phaC mutant S. meliloti 
and was designated as SmUW256. SmUW256 also exhibited fluorescence when growing 
on the YEM plate supplemented with mannitol and Nile Red in both inducing and non-
inducing conditions. The result shows that the plasmid-based engineering system is also 
functional in the strain. 
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 Only P(3HB) was able to be produced in SmUW256 around 30% and 15% DCW in non-
inducing and inducing conditions, respectively. This shows that the plasmid-based 
engineering system was not able to incorporate LA monomer to produce novel polymer. 
 GusA activity was investigated when inducing SmUW256 with different IPTG 
concentrations (0, 0.05, 0.4 and 1mM) in a period of 3-day cultivation. The control strain 
SmUW255 that contains the empty plasmid pTH1227 showed a tightly regulated 
promoter with very little leaky GusA activity at the background level. Meanwhile, the 
plasmid-based engineered strain SmUW256 lacked the tight regulation of the tac 
promoter resulting a higher leaky GusA activity at the background level. The highest 
GusA activity was obtained when inducing SmUW256 at the IPTG concentration of 1 
mM; however, this activity was not as high as the activity obtained in the control strain 
SmUW255 at the same growth condition.  
 GusA activity was investigated when inducing SmUW256 at different time points (no 
induction, 1 day-, 2 day- and 3 day-induction) in a period of 3-day cultivation. Again, the 
control strain SmUW255 showed a tightly regulated promoter with very little leaky GusA 
activity at the background level. Meanwhile, the plasmid-based engineered strain 
SmUW256 lacked the tight regulation of the tac promoter resulting a higher leaky GusA 
activity at the background level. The highest GusA activity was obtained when inducing 
SmUW256 at the beginning of cultivation; however, this activity was not as high as the 
activity obtained in the control strain SmUW255 at the same growth condition. 
 P(3HB) accumulation was investigated when inducing SmUW256 with different IPTG 
concentrations (0, 0.05, 0.4 and 1mM) in a period of 3-day cultivation. Unexpectedly, the 
highest P(3HB) content of 25% DCW was obtained most at the background level. 
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P(3HB) content of roughly 15% DCW was obtained when the strain was induced with 
either 0.05 or 0.1 mM IPTG. P(3HB) content of roughly 10% DCW was obtained when 
the strain was induced with either 0.4 or 1 mM IPTG. This indicates that P(3HB) 
production was most efficient at the background level. 
 P(3HB) accumulation was investigated when inducing SmUW256 with 0.4 mM IPTG at 
different time points in a period of 3-day cultivation. The P(3HB) content appeared to 
remain mostly unchanged (25% - 30% DCW) for 1-day, 2-day or no induction. P(3HB) 
content remarkably dropped to 15% DCW when the strain was induced at the beginning 
of cultivation. 
 A strain that had the whole P(3HB) synthesis pathway blocked and be equipped with the 
pTAM plasmid produced PLA up to 3% DCW when cultured in YEM supplemented with 
lactic acid as a sole substrate. This is the first time PLA was produced in S. meliloti. 
 Multiple mutant S .meliloti backgrounds which are deficiency in P(3HB) cycle pathway 
was unable to produce LA precursors, which was observed in the plasmid-based 
engineered strain SmUW256. 
 The P. putida  phaC mutant strain harbouring TAM plasmid (PPUW19) showed a milky 
white phenotype resembling the phenotype of the wild-type harbouring pTAM 
(PPUW21) when growing on LB plates supplemented with sodium octanoate. By 
comparison, the wild-type and mutant strains harbouring the empty plasmid pTH1227 
had a yellowish colony color. The result indicates that the system was also functional in 
P. putida.  
 P(3HB-co- LA-co-3HHx-co-3HO) was first produced in both PPUW19 and PPUW21 
when growing in defined media supplemented with either sodium octanoate or lactic 
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acid. 3HB and LA fraction were obtained more in PPUW19 by comparison with those in 
PPUW21. The highest dry cell weight (DCW) and polymer content were achieved in 
PPUW18 up to 1.3 g/L and 40%, respectively. LA fraction was not able to be detected in 
the wild-type P.putida strain harbouring the empty plasmid pTH1227 (PPUW20). This is 
the first time this type of polymer was found to be produced in bacteria, specifically P. 
putida. 
 P(3HB-co-LA-co-3HHx-co-3HO) was also produced in both strains PPUW19 and 
PPUW21 when growing in LB media supplemented with either sodium octanoate or 
lactic acid. The strain PPUW20 hardly produced polymers as efficient as strains 
harbouring pTAM.  
 Several native S. meliloti promoters of different strength were selected and introduced 
into pTAM to replace the inducible Tac promoter and drive the expression of the 
aforementioned synthesized genes and gusA reporter gene. It was found out that the 
relative promoter activities which were indirectly assessed via GusA activity were not 
consistent with the results in a previous study. 
 Removal of the insert brought the activities back to the initial activities that have been 
reported in previous study, suggesting the sequence in the synthesized genes influenced 
the promoter strength. 
 The abundance of RNA analyzed by dot blot seems correlated to the results given by 
indirect measurement of GusA activity; therefore, the change might occurred at the 
transcriptional level.  
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Chapter 1 Literature review 
1.1 Introduction 
Since the 1940s, petroleum-based plastics have become ever more prevalent. Plastics 
have been major players in the development of modern society, and they are now one of the most 
important classes of structural materials. These plastics are made from various synthetic 
polymers such as polyethylene (PE), polypropylene (PP), polystyrene (PS), poly(-ethylene 
terephthalate-) (PET) and poly(-vinylchloride-) (PVC) (Amass et al. 1998). There are, however, 
some inevitable drawbacks. Chief among these, the use of nonrenewable sources of material for 
the production of commodity plastics as well as accumulation of waste in landfills and the 
oceans poses a direct threat to wildlife and human health. Hence, it is ultimately necessary to 
substitute new biodegradable materials for these traditional plastics.  
A variety of potential biodegradable plastics have been intensively and extensively 
investigated, such as polyhydroxylalkanoates (PHA), polylactic acid (PLA), polyglycolic acid 
(PGA), and blends of these polymers (Amass et al., 1998; Kolybaba et al., 2003). These 
polymers are produced in microorganisms from renewable source, or from renewable source 
using synthetic methods. Biodegradable polyesters are able to be commercially produced through 
chemical synthesis, using either polycondensation or ring-opening polymerization. However, 
polymer production based on chemical processing still encounters a number of serious issues 
such as requirement for high temperature, long reaction times, and uncontrollable chain length or 
monomer restriction (Jung et al., 2010b; Okada, 2002). Although major rationales for producing 
these polymers are environmental preservation and human health protection, this is not always 
achieved. For example, chemical synthesis of PLA results in harmful left-over chemical residues 
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from the metal catalysts used in the reaction (Taguchi et al., 2008). The recent trend of using 
enzymes as catalysts is more advantageous than organic synthesis due to higher regiospecificity 
and stereospecificity. However, problems with maintenance of catalytic enzyme activity in non-
aqueous media and the expensive cost of enzyme purification hinder the production of these 
polymers on the industrial scale (Gross et al., 2001; Okada, 2002). 
1.2 Types of PHAs 
PHA is a native product accumulated in various types of bacteria as carbon and energy 
storage materials under nutrient-limiting conditions in the presence of an abundance of carbon 
source (Anderson and Dawes, 1990). A variety of bacteria have been reported as native PHA 
producers such as Cupriavidus necator H16 (formerly, Ralstonia eutropha H16) (Doi et al., 
1992; Peoples and Sinskey, 1989; Schubert et al., 1988; Slater et al., 1988), Alcaligenes latus 
(Hrabak, 1992; Braunegg and Bogensberger, 1986), Pseudomonas (Fritzsche et al., 1990; Gross 
et al., 1989; Huisman et al., 1991; Timm et al., 1994; Timm and Steinbuchel, 1992), Aeromonas 
(Doi et al., 1995), Rhodococcus ruber (Pieper and Steinbiichel, 1992). Syntrophomonas wolfei 
(McInerney et al., 1992) and the rhizobia (Trainer and Charles, 2006). PHAs consist of various 
monomer units in D(-) configuration ranging from 3 to 16 carbon monomers. This wide range of 
monomers provides PHAs with diverse material properties, thermoplastics classified as short 
chain length (SCL) PHAs consisting of 3- to 5-carbon monomers, elastomers as medium chain 
length (MCL) PHAs consisting of 6- to 16-carbon monomers and their copolymers showing 
intermediate properties. While over 100 types of PHAs have been described, the most common is 
the SCL-PHA, poly-3-hydroxybutyrate (P(3HB)). 
  
3 
 
 
Figure 1.1 Chemical structure of different types of polymers 
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1.3 PLA/ P(LA-co-3HB) copolymer 
Polylactic acid (PLA) is a biodegradable polymer that is currently produced chemically 
from biologically produced lactic acid derivatives using heavy metal catalysis (Taguchi et al., 
2008), but is not known to be naturally produced by any microbe. It possesses several favourable 
properties such as high strength, biocompatibility, heat resistance, permeability and optical 
activity that make it a leading candidate for medical applications such as resorbable sutures, drug 
carriers, organ-substituting implants and artificial blood vessels (Lunt, 1998; Södergård and 
Stolt, 2002). The co-polymer PLA-co-PHA has been obtained through ring-opening 
polymerization of L-lactide combined with PHA using stannous octoate as a catalyst as shown in 
Figure 1.2 (Haynes et al., 2007).  In part to avoid contamination with trace levels of heavy metal 
(Figure 1.3), research has focused on producing PLA and similar types of polymers through 
direct fermentation (Selmer et al., 2002; Jung et al., 2010; Yang et al., 2010), despite the absence 
of natural production. It was determined that lactic acid (LA) and 3-hydroxyalkanoate (3HA) 
monomer, especially D-3-hydroxybutyrate, share a similar structure including both hydroxyl and 
carboxyl groups essential for the formation of an ester bond (Yang et al., 2010).  
  
5 
 
 
 
Figure 1.2 Synthesis of PHA-co-PLA via ring-opening polymerization (Adapted from Haynes et 
al., 2007) 
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Figure 1.3 Synthesis  of  oligoNodax-b-PLLA (Adapted from Schreck and Hillmyer, 2007) 
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1.4  Physical properties of different types of polymers 
 Physical characterization of PLA, PHA and novel copolymers has been carried out in 
previous studies to enhance favourable properties and circumvent individual drawbacks of each 
homopolymer (Haynes et al., 2007; Noda et al., 2004; Noda et al., 2005; Schreck and Hillmyer, 
2007). The properties of the polymer can be well-defined based on the type, content, monomer 
composition, as well as molecular weight and molecular weight distribution. P(3HB) 
homopolymer exhibits undesirably high crystallinity which causes a limited range of applications 
due to its hard and brittle properties (Noda et al., 2005). Another disadvantage of P(3HB) is that 
it is difficult to process using the melting method since it has a high melting temperature 
(>170ºC) which is close the thermal decomposition temperature. Incorporation of another SCL 
3HA (3HV) did not help to circumvent these limitations. Meanwhile, MCL PHAs which contain 
higher carbon number (6-14 carbons)  are described as having low melting points, high elasticity 
and biodegradability (Jiang et al., 2006). Since the melting temperature of MCL PHAs is pretty 
low varying from 39ºC to 61ºC,materials made from MCL PHAs are not rigid enough and tend 
to lose their coherence at rather low temperature (Koning, 1995). However, incorporation of a 
small amount of MCL PHAs into P(3HB) showed some improved properties of the target 
polymers. Their properties were described as similar to polyethylene, which is relatively tough 
and ductile. The crystallinity and melting temperature (Tm) of P(SCL-co-MCL 3HA) are 
decreased significantly in comparison with the traditional PHA polymers, such as P(3HB) or 
PHBV copolymers. Therefore, this type of copolymer was able to be processed efficiently and in 
a cost-saving way. Another advantage is that the complete degradation of these copolymers can 
be achieved in either aerobic or anaerobic environments.   
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It was reported that PLA has a glass transition temperature (Tg) of ca. 60ºC and Tm of ca. 
170ºC, whilst Tg of PHA varies from -10ºC and 0ºC, and its Tm fluctuates between 160ºC and 
180ºC (Haynes et al., 2007). Physicochemical properties of P(3HB-co-LA) including the 
molecular weight, thermal properties, and melt viscosity were taken into account as well. The 
mole fraction of LA monomer was inversely proportional to the molecular weight and the 
crystallinity of P(3HB-co-LA), and directly proportional to the glass transition temperature (Tg) 
of the polymer (Yang et al., 2010). While Tg was apparently affected by LA fraction, melting 
temperature (Tm) was just slightly changed according to LA monomer composition and 
maintained around 160ºC. Copolymer showed a decreased molecular weight of 29,000 compared 
to that of PHA which had a molecular weight of 126,000. Also, this copolymer exhibits more 
favourable changes in thermal behavior as well as the glass transition and the crystallization 
transition. Furthermore, improved mechanical properties, such as lower viscosity and dynamic 
moduli which PLA alone cannot possess, have been obtained for this copolymer. There was also 
an attempt to blend MCL PHA with PLA using a melt-mixing method and the properties of the 
new blended polymers were examined (Noda et al., 2004). It was reported that the new polymer 
possessed much improved properties such as increased toughness and ductility as well as optical 
clarity.  
1.5  Sinorhizobium meliloti and  its P(3HB) pathway 
Sinorhizobium meliloti, a soil bacterium, best known for its N2-fixing symbiosis with 
Medicago sativa (alfalfa), is genetically amenable and metabolically versatile (Bélanger et al., 
2009b; Gurich and González, 2009). It has the advantage of having been used for many years in 
the agricultural inoculant industry, and is culturable to very high titres. It is a native P(3HB) 
producer that can accumulate P(3HB) on the order of 60-80% cell dry weight under growth-
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limiting conditions in the presence of excess carbon source (Trainer and Charles, 2006). The 
P(3HB) cycle in S. meliloti, which includes the well-studied P(3HB) synthesis and degradation 
pathways (Figure 1.4), resembles the P(3HB) cycles in other native P(3HB) producers (Charles 
et al., 1997). The first step in this cycle is the conversion of acetyl-CoA into acetoacetyl-CoA 
catalyzed by phbA-encoded ketothiolase (EC 2.3.1.9). This is followed by acetoacetyl-CoA 
reductase (EC 1.1.1.36) encoded by phbB to convert acetoacetyl-CoA into 3-hydroxylbutyryl-
CoA. In the last step of the P(3HB) synthesis pathway, phbC-encoded P(3HB) synthase (EC 
2.3.1.B2) is responsible for polymerizing 3-hydroxylbutyryl-CoA into PHB. In S. meliloti, other 
enzymes taking part in the P(3HB) degradation pathway are P(3HB) depolymerase (phaZ) (EC 
3.1.1.75), D-3-hydroxybutyrate dehydrogenase (bdhA) (EC 1.1.1.30), and acetoacetyl-CoA 
synthetase (acsA2) (EC 6.2.1.16).  The P(3HB) depolymerase carries out the first step to cleave 
P(3HB) into D-3-hydroxybutyrate monomers. Next, these monomers are oxidized and converted 
to acetoacetate by the action of D-3-hydroxybutyrate dehydrogenase. The last step which 
supplies P(3HB) production precursors (acetoacetyl-CoA) is catalyzed by acetoacetyl-CoA 
synthetase.  
Interestingly, the P(3HB) synthase-encoding gene, is not co-localized with other P(3HB) 
synthesis genes in the genome of S. meliloti (Trainer and Charles, 2006). This pattern was found 
to be common among other PHB-accumulating bacteria such as Caulobacter crescentus, 
Azorhizobium caulinodans, Rhizobium etli, Paracoccus denitrificans and Methylobacterium 
extorquens. Meanwhile, in the -proteobacterium C. necator for example, three P(3HB) 
biosynthesis genes are located in a single operon in the order of phaC, phaA and phaB. These 
genes are arranged in the opposite order in the -proteobacterium A. vinelandii. Although phbC 
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is located by itself in the S. meliloti genome, the two other genes (phbA and phbB) are found 
within a separate operon.  
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Figure 1.4 P(3HB) biosynthesis and degradation pathways 
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1.6 Pseudomonas putida strain and MCL-PHA pathway  
 Pseudomonas putida KT2440 and its rifampicin-resistant derivative KT2442 have been 
employed extensively to investigate the capability of MCL PHA production. These laboratory 
workhorses are unable to accumulate PHB, but able to polymerize MCL PHA during unbalanced 
growth conditions up to 75% PHA (Sun et al., 2007). This characteristic was also found among 
other Pseudomonas strains belonging to rRNA homology group I such as P. aeruginosa and P. 
oleovorans (Huisman et al., 1989; Huisman et al., 1992). Normally, the majority of monomers 
produced in these strains have the same number of carbons as the substrates provided to the 
cultures; others could be cleaved by one or more C2 units. Depending on the type of growth 
substrates provided, two main metabolic pathways operate in these strains to supply precursors 
for MCL PHA production, the -oxidation pathway and the fatty acid de novo biosynthesis 
pathway. Feeding the strains with medium- or long-chain alkanols/ fatty acids could lead to 
accumulation of MCL PHA through the –oxidation pathway, while using glucose and other 
substrates that are unrelated to the above mentioned substrates can supply MCL PHA precursors 
through the fatty acid de novo biosynthesis pathway (Figure 1.5) (Huijberts et al., 1992). These 
pathways are the sources to supply substrates of the PHA substrates, namely 3-hydroxyacyl 
coenzyme A thioesters. In addition to these two main pathways, there is another reported side 
metabolic route of supplying 3-hydroxyacyl-CoA from acetyl-CoA through chain elongation 
reaction when hexanoate is used as a substrate (Hoffmann and Rehm, 2004a; Huijberts et al., 
1994). PHA synthesis was found to start in exponential growth phase, reach the maximum 
amount of 50% cell dry weight at the beginning of stationary phase, and then remain unchanged 
thereafter (Huisman et al., 1992).  
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PHA biosynthesis genes in P. putida are located in the phaC1ZC2D operon which is 
composed of two PHA polymerase genes (phaC1 and phaC2), a depolymerase gene (phaZ), and 
a transcriptional regulatory gene (phaD) (Luengo et al., 2003). An additional cluster of two 
phasin genes (phaI and phaF) involved in PHA biosynthesis is located downstream of 
phaC1ZC2D, arranged in the opposite orientation. The phaF gene is known to be a negative 
regulator which represses the transcription of the PHA synthase gene (phaC1) and the other 
phasin gene (phaI) (Hoffmann and Rehm, 2004b). The more PHA is accumulated in the strain, 
the more phasin protein PhaF is bound to the surface of the PHA granule; hence, less freely 
available PhaF could lead to the transcriptional enhancement of phaC1 and phaI. The key 
enzyme, PhaG transacylase, plays an intermediate role by linking fatty acid de novo biosynthesis 
with PHA biosynthesis by replacing the acyl carrier protein moieties with CoA thioesters (Rehm 
et al., 1998; Hoffmann et al., 2002). Owing to the PhaG enzyme, the strain is able to produce 
PHAs from non-related carbon sources such as sugars and gluconate. 
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Figure 1.5 MCL PHA production pathway in P. putida. 
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1.7 Metabolic engineering in native producers 
There are a number of different strains which naturally accumulate polymers under 
certain conditions such as nutrient limitation (N, P, Mg, or O) or carbon source abundance 
(Anderson and Dawes, 1990). These strains includes Cupriavidus necator H16 (formerly, 
Ralstonia eutropha H16), Alcaligenes latus, Pseudomonas putida KT2440, Aeromonas, 
Rhodococcus ruber, Syntrophomonas wolfei and others. However, these native polymer 
producers still need to be improved to further meet the industry demands for commercialization 
in terms of economical profit and intrinsic properties for practical applications. Therefore, these 
strains need to be further engineered using metabolic tools so that they can meet the industrial 
demands. 
1.7.1 Short-chain-length native producers 
Among the short-chain-length native producers, the β-Proteobacteria A. latus and C. 
necator are the most popular model systems for in-depth studies in polymer biosynthesis. C. 
necator strain H16 was able to accumulate P(3HB) up to 80% CDW from glucose, exhibited 
rapid growth, and has the ability to use different substrates including ethanol, glucose and 
hydrogen/carbon dioxide/air (Byrom, 1987; Holmes, 1985).  P(3HB) produced by C. necator 
was successfully commercialized by a company called ICI. However, due to its brittle properties, 
there are challenges to find alternative materials with better properties, yet their production 
remains equally cost-effective. Surprisingly, in addition to the primary 3HB monomer, a small 
amount of MCL PHAs (3HHx and 3HO) were detected in fatty acid β-oxidation inhibited C. 
necator. In this study, sodium acrylate was used as a β-oxidation inhibitor and sodium octanoate 
as a carbon source (Green et al., 2002). Applying two-stage cultivation resulted in the increase of 
3HHx (10.2%) and 3HO (1.6%), and 3HP (6.5%). Substitution of the native C. necator PHA 
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synthase with the P. aeruginosa Class II PHA synthase PhaC1 also led to MCL production 
(3HHx, 3HO and 3HD) in the presence of various acrylic acid concentrations and with decanoate 
as the carbon source. Copolymer P(3HB-co-1.5% mol 3HHx) up to 48% DCW was achieved in 
recombinant C. necator strains harbouring crotonyl-CoA reductase gene from Streptomyces 
cinnamonensis (ccrSc) and PHA synthase and (R)-specific enoyl-CoA hydratase genes from 
Aeromonas caviae (phaC-JAc) using fructose as a substrate (Fukui et al., 2002). After further 
development, the same copolymer P(3HB-co-3HHx) was also obtained with very high polymer 
content (40% - 87% DCW) and 3HHx fraction up to 5% mol from renewable substrates (palm 
kernel oil, palm olein, crude palm oil and palm acid oil) in engineered C. necator strains 
harbouring the PHA synthase gene from Aeromonas caviae (Loo et al., 2005). Expressing tailor-
made derivatives of PHA synthase from Aeromona caviae in C. necator enabled production of 
P(3HB-co-3HHx) with adjustable 3HHx monomer composition (Tsuge et al., 2004). These 
mutated PHA synthases were made to increase enzyme activity towards the (R)-3HB-CoA 
monomers by using in vitro evolutionary engineering techniques. 
1.7.2 Medium-chain-length native producers 
Pseudomonas strains were considered as a model system for further development of 
MCL-PHA production because of their ability to produce MCL PHAs naturally. To allow 
production of SCL/MCL PHA copolymer, specifically P(3HB-co-3HHx), a 5-kb fragment from 
Aeromonas caviae genomic DNA which included the PHA synthase gene (phaCAc) together with 
four open reading frames (ORFs) and one putative promoter region was introduced into P. putida 
PHA-negative mutant (Fukui and Doi, 1997). It was revealed that ORF3 showed (R)-enoyl-CoA 
hydratase activity, hence it supplied (R)-3-hydroxyacyl-CoA monomer units. Since it was known 
that the transacylase gene (phaG) links the fatty acid de novo synthesis and PHA synthesis, two 
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different phaG genes from P. putida and P. oleovorans were examined in different Pseudomonas 
strain backgrounds (Hoffmann et al., 2000). Both genes functioned similarly in a phaG mutant of 
P. putida KT2440 which produced MCL PHAs of similar monomer composition. More 
interestingly, P. oleovorans, which marginally accumulated MCL PHA from non-related carbon 
sources even under inducing conditions was then recovered to produce MCL PHA by 
introduction and expression of phaG from either P. putdia or P. oleovorans. A defective β-
oxidation pathway in P. putida resulted in MCL PHA production with a high content of a 
particular monomer (Liu and Chen, 2007). The fadA fadB mutant of P. putida was able to 
accumulate MCL PHAs consisting of 31- 49 mol% 3-hydroxytetradecanoate as a major 
monomer when using tetradecanoic acid as a sole carbon source. The same mutant strain 
accumulated 50% DCW MCL PHAs higher than the parent strain KT2440 when dodecanoate 
was used as a carbon source (Ouyang et al., 2007). In addition, the monomer composition 
obtained in the mutant strain had 3-hydroxydodecanoate content that was 5 times greater than 
that of the parent strain. This 3HDD fraction even further increased up to 75% in a two-step 
fermentation process after 16 h cultivation, and then decreased over time. For an efficient PHA 
production, PHA concentration and PHA productivity need to be taken into account. It was 
found out that an optimized initial KH2PO4 concentration increased PHA concentration and PHA 
content up to 72.6 g/l and 51.4% CDW, respectively, in P. putida by fed-batch cultivation using 
oleic acid as a substrate (Lee et al., 2000). As mentioned earlier, substrate cost contributes a 
major portion of PHA production cost. Xylose, a hemicellulose derivative, is one of the most 
inexpensive carbon sources. MCL PHAs could be obtained in engineered P. putida KT2440 
from xylose and octanoic acid when two genes encoding xylose isomerase (XylA) and 
xylulokinase (XylB) from E. coli W3110 were expressed in the P. putida strain (Le Meur et al., 
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2012). Technically, xylose was used to support the cell growth, while octanoic acid was to 
supply MCL PHA precursor. The combination of non-related and related carbon source is a 
feeding strategy to avoid unnecessary use of expensive fatty acids. Bioinformatics also provides 
powerful tools to construct a robust Pseudomonas system by identifying target genes to be either 
deleted or over-expressed. For example, based on a genome-wide in silico prediction, genes 
encoding for pyruvate dehydrogenase subunit (AcoA) and glucose dehydrogenase (Gcd) were 
potential target genes to be engineered for the improvement of MCL PHA production using 
glucose as sole carbon source (Borrero-de Acuña et al., 2014). Overproduction of AcoA resulted 
in the increase of MCL PHA by 33% in the wild-type strain, and by 121% in the gcd mutant 
strain.  
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1.8 Metabolic engineering in non-native producers 
1.8.1 In Bacteria: Escherichia coli 
Escherichia coli has been the most widely used model system in the metabolic 
engineering field for the reason that it can grow fast in a relatively inexpensive medium, and is 
easy to lyse. Since it is not a native producer, however, it does not possess a depolymerase that 
can degrade polymer. Also, there are various options of genetic and molecular tools which have 
been developed for this specific strain over several decades. These advantages result in a shorter 
cycle time for the production process, a lower cost of fermenter operation as well as purification, 
and relatively easy genetic modification.   
1.8.1.1 Short chain length (SCL) PHAs, medium chain length (MCL) PHAs and copolymer 
SCL/MCL PHAs  
P(3HB) production in E. coli was first investigated almost two decades ago (Lee and 
Chang, 1995; Choi et al., 1998; Genser et al., 1998). Among different E. coli strains, it was 
found that XL1-Blue was the most promising host for P(3HB) production because it can 
accumulate up to 81% with the PHA concentration of 7.2 g/l (Lee and Chang, 1995). In a follow-
up study, the strain was equipped with either the A. latus PHA biosynthesis system (phaCABAl) 
or C. necator H16 PHA biosynthesis system (phaCABCn). It was reported that the recombinant E. 
coli strain harbouring phaCABAl showed a higher productivity than the recombinant phaCABCn 
strain (Choi et al., 1998). A similar result was also obtained when using a different E. coli strain 
(Genser et al., 1998). Even though the author pointed out the advantages of using E. coli as a 
P(3HB) production machine and obtained better results when combining this host with the better 
PHA biosynthesis system phaCABAl, there were still questions about whether such recombinant 
strains of E. coli could outperform the wild-type native PHA producers. 
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Further studies demonstrated that the gene order of the phaCAB operon can contribute to 
the improvement of the properties of produced P(3HB). By rearranging the order of these genes 
from C. necator and expressing them in E. coli, it was found that gene order affects both the 
molecular weight and level of P(3HB) accumulation. In general, increase of molecular weight 
was accompanied by decrease in polymer yield. The phaBCA gene order represented the best 
compromise between them. It was also found that the de novo fatty acid biosynthesis pathway 
was able to supply 3HB precursors as long as the strain was equipped with genes encoding 
certain key enzymes: 3-ketoacyl-ACP synthase III (FabH) or malonyl-CoA-ACP transacylase 
(FabD) that links this pathway with the PHA biosynthesis pathway. Co-expression of either fabH 
or fabD with phaC resulted in P(3HB) production of 5-11% CDW (Taguchi et al., 1999). 
In addition to P(3HB) homopolymer production in E. coli, other studies also attempted to 
incorporate 3HV, another type of SCL PHA, into P(3HB) to create P(3HB-co-3HV) copolymer 
(Choi and Lee, 1999; Slater et al., 1992; Wong et al., 2008; Yim et al., 1996). The engineering 
strategy was similar to that used to produce P(3HB) homopolymer except for substrate feeding. 
In order for E. coli strains to be able to produce 3HV monomer, propionate was added into the 
media to supply sources for 3HV production. A recombinant E. coli strain LS5218 harbouring 
P(3HB) biosynthesis genes from C. necator was able to accumulate P(3HB-co-3HV) up to 30% 
mol 3HV (Slater et al., 1992). Varying either glucose or propionate concentration in the media 
resulted in various 3HV monomer compositions. In another study that investigated the P(3HB-
co-3HV) accumulation ability among different E. coli host strains, XL1-Blue was shown again to 
be the best E. coli strain for this copolymer production in terms of both PHA content and 3HV 
fraction (Yim et al., 1996). There was no clear explanation for why this strain was able to 
outperform other E. coli strains at P(3HB) production. Unlike other non-E.coli strains, this 
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recombinant strains did not produce copolymer from valerate because Ato enzymes which were 
required to convert valerate into valeryl-CoA were not induced by valerate. Ato enzymes are the 
products of the following genes: atoA (CoA transferase), atoB (thiolase) and a regulatory gene 
atoC (Pauli and Overath, 1972). These enzymes take part in the degradation of acetoacetate to 
acetate and acetyl-CoA. It was also hypothesized that propionate was transported and activated 
to propionyl-CoA by an undefined acetate transport system which could include glyoxylate shunt 
enzymes and acetate-activating systems involving acetate kinase and phosphotransacetylase. 
Conversion of propionyl-CoA from propionate was also expected to be improved by introducing 
propionyl-CoA synthetase gene (prpE) from Salmonela enterica (Wong et al., 2008). However, 
3HV was not efficiently incorporated into polymer; hence 3HV molar content was obtained only 
between 5% and 18% depending on the expression level of PrpE under the control of the 
isopropyl β-D-1-thiogalactopyranoside (IPTG)-inducible tac promoter despite the fact that there 
was an abundance of propionyl-CoA produced. The reason might be that the PHA operon and 
conditions were not optimized for higher 3HB proportion. 
Since MCL PHAs (C5-C14) and SCL/MCL copolymer PHAs showed more favourable 
properties than SCL PHAs, other studies shifted toward engineering E. coli for the production of 
these PHAs. Two strategies which have been used to engineer E. coli for MCL PHA production 
are to engineer either the fatty acid β-oxidation pathway or the de novo fatty acid biosynthesis 
pathway. For the fatty acid β-oxidation pathway, the approach involved inhibition/ 
deletion/substitution of the β-oxidation multienzyme complex, such as  FadA/FadB (Langenbach 
et al., 1997; Snell et al., 2002), or overexpression  of desired enzymes, such as enoyl-CoA 
hydratase and 3-ketoacyl-CoA (ACP) reductase (Taguchi et al., 2001), or a combination of these 
(Park et al., 2002) to increase the precursor flow toward MCL PHA polymerization.  
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The first study in this line of research was published in 1997 by Langenbach et al. 
(Langenbach et al., 1997). In this study, they investigated the production of MCL PHA in 
recombinant E. coli by expressing the Pseudomonas aeruginosa PHA synthase gene phaC1. 
Various E. coli strains as well as different media were tested for MCL PHA production. As a 
result, the E. coli fadB mutant strain LS1298 harbouring the above PHA synthase gene cultivated 
in LB medium containing 0.5% (w/v) decanoate most efficiently produced MCL PHA (21% 
CDW) consisting of 2.5% mol 3-hydroxyhexanoate, 20% mol 3-hydroxyoctanoate, 72.5% mol 
3-hydroxydecanoate and 5% mol dodecanoate (Langenbach et al., 1997). The same group also 
looked at the polymer production in E. coli when expressing the second PHA synthase gene 
phaC2 from Pseudomonas aeruginosa (Qi et al., 1997). When dodecanoate was used as a carbon 
source, recombinant E. coli produced MCL PHA (15% CDW) composed of 35% mol 3-
hydroxydodecanoate, 60% mol 3-hydroxydecanoate and 5 % mol 3-hydroxyoctanoate. Also, the 
study concluded that the two PHA synthases from P. aeruginosa possess similar characteristics 
which led to similar PHA production in terms of monomer composition and molecular mass.  
The expression of the enoyl-CoA hydratase encoding gene phaJ from Aeromonas caviae 
was investigated in a recombinant E. coli strain (Fukui et al., 1999). The co-expression of this 
gene and phaCac resulted in SCL/MCL PHA accumulation (7-11% CDW) in E. coli strain 
LS5218. The homologous phaJ genes (phaJ1Pa  and phaJ2Pa) from P. aeruginosa, were also co-
expressed with PHA synthase genes from Aeromonas caviae (phaCac) or Pseudomonas sp. 61–3 
(phaCPs) in E.coli LS5218 [fadR601, atoC2(Con)] (Taguchi et al., 2001; Tsuge et al., 2000). 
Depending on the PHA synthase genes used, different types of SCL/MCL copolymers were 
produced. The PHA synthase gene phaCac incorporated more SCL PHA (3HB) into the polymer 
while the PHA synthase gene phaCPs  favoured MCL PHA incorporation. These results 
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suggested that these hydratase genes are essential for driving precursors from the β-oxidation 
pathway toward polymer production in E.coli. 
Following up on this study, other groups searched for enzymes homologous to PhaJ. The 
role of the E. coli enzyme YfcX, which belongs to the crotonase superfamily of enzymes, has 
been investigated for its association with MCL PHA production in E. coli (Snell et al., 2002). 
The fadB yfcX mutant E. coli harbouring P. oleovorans phaC1 was unable to accumulate any 
MCL PHAs. However, genetic complementation of yfcX in this strain restored the ability to 
produce MCL PHAs from both palmitate and decanoate substrates. Another enzyme in the 
crotonase superfamily of enzymes, MaoC, has been investigated for homologous function of 
enoyl-CoA hydratase (Park and Lee, 2003). A fadB maoC mutant strain exhibited significantly 
reduced amounts of MCL PHA accumulated (43%) compared to the fadB mutant strain. 
Restoring the function of the maoC gene in the double mutant strain improved the amount of 
MCL PHA. However over expression of maoC in a fadB mutant did not result in as much MCL 
PHA accumulation as was achieved after complementation of FadB in this strain. Also, deletion 
of both MaoC and FadB impaired MCL PHA accumulation less than deletion of both YfcX and 
FadB. These results showed that MaoC played a less important role in the β-oxidation pathway 
than YfcX, hence affected the ability of MCL PHA accumulation less. Along with YfcX and 
MaoC, five other enzymes including PaaG, PaaF, BhbD, SceH, and YdbU, also have been 
investigated (Park and Lee, 2004). The wild-type E. coli strain W3110 which has a full β-
oxidation pathway was unable to produce any MCL PHAs regardless of introducing the PHA 
synthase gene alone or along with each of the aforementioned genes. However, co-expression of 
the PHA synthase gene and one of these genes in a fadB mutant strain increased the amount of 
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MCL PHAs accumulated compared to expression of PHA synthase gene alone, and it even 
increased MCL PHA concentration roughly twice for the expression of paaG, paaF and ydbU.  
The combination of both expression of 3-ketoacyl-ACP reductase genes and deletion of 
fadA could lead to specific monomer enrichment in MCL PHAs (Park et al., 2002). 
Overexpression of the E. coli fabGEc gene led to MCL PHA rich in 3-hydroxydecanoate 
monomer up to 93 mol% in fadA mutant E. coli strain. Other enzymes, such as encoded by fadD, 
fadL and fadE, also have been investigated for modulating monomer composition in fadA and/or 
fadB mutant E. coli strains (Park et al., 2003). Enrichment of 3HD was able to be obtained up to 
78% mol by expression of fadD gene only in a fadA mutant strain. The co-expression of fadE 
and fadD resulted in the increase of C10 and C12 monomers when decanoate and dodecanoate 
were used as the substrates, respectively.  
  The drawback of targeting the β-oxidation pathway to develop MCL PHA producers is 
that this involves supplementation with fatty acids, and fatty acids are toxic to the cells and not 
economically viable. Therefore, sugars were considered to be a more favourable substrate for 
PHA production. The use of sugars involves engineering an alternative pathway that is the de 
novo fatty acid biosynthesis pathway. The phaG gene plays an important role in linking this 
pathway and the PHA biosynthesis pathway (Park et al., 2005b). Since E. coli is not a native 
PHA producer, the fatty acid biosynthesis pathway does not efficiently supply the source of R-
3HA-ACPs which are substrates for the transacylase PhaG. Therefore, expression of the phaG 
and phaC genes did not enable this strain to accumulate MCL PHA (Rehm and Mitsky, 2001). 
However, either the disruption  of FabA/ FabI or the chemical inhibition of FabB (β-ketoacyl-
ACP synthase I) and FabF (β-ketoacyl-ACP synthase II) did not change this incapacity. 
Interestingly, the application of triclosan, a specific inhibitor of the enoyl-ACP reductase FabI, 
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led to a small amount of MCL PHA detected (2-3% CDW) from non-related carbon source when 
both phaG and phaC were expressed in E. coli. It is still unclear what made the difference 
between the fabI mutant strain and the chemical inhibited fabI strain, which allowed only the 
latter to produce MCL PHA. Triclosan was added to the medium after a 24 hr incubation, so it 
might be that FabI was required at the beginning to produce MCL PHA precursors.  
Another study also proposed alternative transacylase enzymes (FabH, FabD) which also 
can link the de novo fatty acid biosynthesis pathway and the PHA biosynthesis pathway (Taguchi 
et al., 1999). However, as mentioned earlier, the co-expression of these genes with phaC only led 
to P(3HB) production in E. coli. The reason why only SCL PHA was produced could be that 
PhaC synthase from Aeromonas caviae preferred 3HB monomers or there was insufficient 
source of MCL 3HA monomers supplied from this pathway when glucose was added as a carbon 
source. Further genetically engineering  fabH created a novel enzyme activity which was able to 
convert 3-ketoacyl-ACP into 3-ketoacyl-CoA (Nomura et al., 2004). The codon encoding the 
amino acid 87 of FabH protein sequence was modified to replace the Phe residue with various 
other residues by saturation point mutagenesis. The rationale of this work was that this 
modification would broaden enzyme substrate specificity toward longer-chain fatty acids since 
M. tuberculosis FabH with a Thr residue at position 87 displayed substrate specificity toward C8 
- C16. Some of the point mutant fabH genes showed an increase of MCL-3HA fraction when co-
expressed with either Pseudomonas sp. strain 61-3 phaC1 gene or A. caviae phaC gene. The co-
expression of engineered fabH gene with phaCAc gene resulted in the incorporation of C6 
monomers into C4 monomers, and obtained the highest fraction of C6 up to 5.8% with 
engineered FabH (F87C). Not only C6 but also C8 and C10 monomers were able to be detected in 
an E. coli strain harbouring engineered FabH and PhaCPs.  
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In another study, it was found that there is a link between the fatty acid β-oxidation 
pathway and the central metabolic pathway through an enzyme called thioesterase I (Test A) 
(Klinke et al., 1999). Therefore, PHA precursors could be obtained from non-related substrates 
such as sugars or gluconate through the fatty acid β-oxidation pathway. E. coli JMU193, a fadB 
mutant, was able to produce MCL PHAs consisting of C6, C8 and C10 up to 2.3% from gluconate 
by being introduced with a MCL PHA polymerase and the cytosolic thioesterase I.  
1.8.1.2 PLA homopolymer, P(LA-co-3HB) copolymer and P(LA-co-3HB-3HV)/P(LA-co-
3HB-co-3HHX) terpolymer 
In the last decade and a half, PLA and a novel copolymer P(LA-co-3HB) has emerged as 
a promising bioplastic. This copolymer was first reported by a group of researchers from Japan 
in 2008 (Taguchi et al., 2008). This study triggered a series of subsequent studies to improve 
both polymer content as well as LA fraction (Jung et al., 2010b; Nduko et al., 2014; Shozui et al., 
2011; Yamada et al., 2010; Yang et al., 2010; Yang et al., 2011). In the first report, Taguchi and 
colleagues successfully introduced LA monomer into P(3HB) to biosynthetically produce P(6 
mol% LA-co- 94 mol% 3HB) copolymer by employing two enzymes propionate-CoA 
transferase (Pct) from Clostridium propionicum and engineered PHA polymerase (PhaC) from 
Pseudomonas sp. 61–3 in E.coli JM109. Not too long after, another group of researchers further 
investigated these two enzymes by using random mutagenesis of the pctcp gene and site-directed 
mutagenesis as well as saturation mutagenesis of the phaC1Ps6-19 gene (Yang et al., 2010). Three 
mutants (E130D, S325T, and Q481M) in the phaC1Ps6-19 gene were generated to modify enzyme 
activity towards SCL 3HAs by using site-directed mutagenesis. Other modifications for the 
phaC1Ps6-19 gene were performed using saturation mutagenesis to create a series of different 
combinations of mutated amino acids at the 310, 325, 481 and 477 sites. A wide range of LA 
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fractions from 20-49 mol% was obtained when these engineered enzymes were expressed in E. 
coli. An even wider range of LA fractions (9-64 mol%) could be achieved by fed-batch cultures. 
The effect of modification at these sites (E130, S325, S477 and Q481) was also investigated in 
other type II Pseudomonas PHA synthases 1 (PhaC1s) from Pseudomonas chlororaphis, 
Pseudomonas sp. 61-3, Pseudomonas putida KT2440, Pseudomonas resinovorans and 
Pseudomonas aeruginosa PAO1 (Yang et al., 2011). All PhaC1 that had mutated sites showed a 
change of substrate specificity towards SCL hydroxyl-CoAs consisting of lactyl-CoA and 3-
hydroxybutyryl-CoA. The engineered phaC1 gene from Pseudomonas sp. 61-3 was further 
improved to finely regulate the LA fraction in the copolymer by saturation mutation at position 
392 (Yamada et al., 2010). By alignment, there is a correlation between site 392 in Type II PHA 
synthase from Pseudomonas sp. 61-3 and site 420 in the PHA synthase from Ralstonia eutropha. 
Previous studies showed that mutation at the position 420 in PHA synthase from Ralstonia 
eutropha enhanced the enzyme activity. Therefore, it could be interesting to examine the position 
392 in engineered PHA synthase from Pseudomonas sp. 61-3. Out of the 19 mutants, there were 
17 that exhibited the ability to incorporate LA with a range of various monomer composition (16 
- 45 mol%).  
In addition to enzyme activity, the culture conditions can have an effect on polymer 
production. It was found that anaerobic conditions could help increase LA monomer composition 
up 62 mol% (Yamada et al., 2010). Not only propionate-CoA transferase and PHA polymerase 
but also the host system was taken into account to produce the copolymer P(LA-co-3HB). Since 
E. coli is not a native polymer producer, it possesses other pathways that produce side products 
such as ethanol and acetate. In order to make it a robust host for polymer production, the ackA, 
ppc and adhE genes have been deleted, and the promoters of the ldhA and acs genes have been 
28 
 
replaced with the trc promoter based on in silico genome-scale metabolic flux analysis (Jung et 
al., 2010b). E. coli JLX10 which possesses all of the above engineered characteristics showed the 
most promising system for polymer production in terms of LA monomer composition and 
polymer content. The pflA mutant E. coli strain JW0885, which had a defective formate synthesis 
pathway from pyruvate, also increased LA fraction in the copolymer (26 mol%) (Shozui et al., 
2010b). The cost-effective strategy which targeted the substrate used for P(LA-co-3HB) 
production was under consideration in a recent study (Nduko et al., 2014). Over-expresssion of a 
galactitol transporter (GatC), which partakes in the ATP-independent xylose uptake, was carried 
out in different mutant E. coli backgrounds. GatC over-expression resulted in an increase of both 
the LA fraction (67, 66 and 64 mol%) and polymer yield (8.3, 6.6 and 7.3 g/l) in mutants (pflA, 
pta and dld mutants, respectively).  
Other terpolymer P(LA-co-3HB-co-3HV) and P(LA-co-3HB-co-3HHx) are novel 
polymers that have recently been discovered (Shozui et al., 2010a; Shozui et al., 2010b; Shozui 
et al., 2011). P(LA-co-3HB-3HV) terpolymer was first obtained in the pflA mutant E. coli strain 
JW0885 by expressing engineered PHA synthase from Pseudomonas sp 61-3 along with three 
other  precursor supplying enzymes such as propionyl-CoA transferase, β-ketothiolase and 
acetoacetyl-CoA reductase (Shozui et al., 2010b). Feeding the recombinant strain with 2% 
glucose and 100 mg/l of sodium propionate resulted in the presence of 7.2 mol% LA monomer. 
The highest LA fraction was achieved up to 96 mol% in a P(LA-co-3HB-co-3HV) terpolymer 
(Shozui et al., 2011). In this study, propionyl-CoA transferase gene (pct) from Megasphaera 
elsdenii, the mutated PHA synthase gene from Pseudomonas sp. 61-3 (phaC1STQK), and the 
(R)-specific enoyl- CoA hydratase gene (phaJ4) from Pseudomonas aeruginosa were introduced 
into E. coli LS5218 to produce the flow toward PHA synthesis from glucose and valerate. 
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However, polymer content was only 0.4 wt% which is not economically efficient for 
commercialization. Another terpolymer P(LA-co-3HB-co-3HHx) was also discovered by the 
same group of researchers (Shozui et al., 2010a). Employing the same set of genes (pct, 
phaC1STQK and phaJ4) resulted in the incorporation of 3HHx through reverse reaction of -
oxidation pathway if the strain was fed with glucose and butyrate. Monomer composition 
consisted of LA (2.7 – 34 mol%), 3HB (38 – 81 mol%) and 3HHx (17 – 33 mol%) and varied 
depending on the concentration of sodium butyrate. However, polymer content is still quite low 
(<4%).  
1.8.2 In yeast: Saccharmyces cerevisae 
With the goal of improving PHA productivity as well as reducing the initial cost, other 
studies have considered yeasts as hosts to produce PHA. Also, studies of PHA formation in 
yeasts might provide valuable information about how peroxisomal metabolism needs to be 
modified to increase PHA production in other eukaryotes, such as plants. However, unlike 
prokaryotes which have been widely and intensively studied for PHA production, eukaryotes 
have still not yet attracted a lot of interests to be employed for PHA production due to the poor 
ability to synthesize and accumulate PHAs. In several studies, PHAs have been detected in low 
concentrations in yeasts compared to that in bacteria. S. cerevisiae, a model yeast widely used in 
the food industry, has been one of potential candidates for PHA production. P(3HB) synthesis 
genes in C. necator and Methylobacterium extorquens have been successfully introduced into S. 
cerevisiae (Breuer et al., 2002). Interestingly, expression of either PHA synthase gene or all three 
P(3HB) genes resulted in P(3HB) accumulation with P(3HB) content of 6.7% and 5.2%, 
respectively.  
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Not only P(3HB) but also MCL PHAs have been successfully produced in S. cerevisiae. 
S. cerevisiae was equipped with the P. aeruginosa PHAC1 synthase modified at the carboxyl end 
for peroxisome targeting (Poirier et al., 2001). This protein harbours 34 amino acids of the 
carboxy-terminal tripeptide ARM from Brassica napus isocitrate lyase. A wide range of even-
chain PHA monomers from 6 to 14 carbons was generated by yeast grown on oleic acids. 
Meanwhile, various odd-chain monomers from 5 to 15 carbons were detected in yeast grown on 
heptadecenoic acid. The maximum PHA content was 0.45% when yeast was fed with oleic acid 
as a carbon source. Another peroxisome targeting signal employed to target PHA synthase to the 
peroxisome was the Ser-Arg-Met terminal tripeptide from the the isocitrate lyase enzyme (ICL) 
(Marchesini et al., 2003). Recombinant S. cerevisiae produced PHA containing even-chain 
monomers of between 6 and 12 carbons. Moreover, it was found out that both a functional 
peroxisome and β-oxidation pathway played an important role in yeast cells for PHA production. 
Scientists tried to produce PHA not only in yeast peroxisome but also yeast cytosol for 
improvement of PHA production. PHA production in cytosol is likely to benefit from a larger 
space which would not depend on the number and volume of peroxisomes, and from profuse 
carbon fluxes present during the growth. A detectable PHA amount has been achieved from 
cytosolic expression of the MCL PHA in wildtype and pex5 mutant yeast which is deficient in 
the transport of perosixomal proteins with the PTS1 signal into organelle (Zhang et al., 2006). 
The maximum PHA content in yeast cytosol was 0.069 %DCW when pex5 mutants were fed 
with both formate and dodecanoic acid. 
The yeast β-oxidation cycle has been modified to channel carbon flux toward SCL-MCL 
PHA biosynthesis (Oliveira et al., 2004). The synthesis of SCL-MCL PHA copolymer containing 
3 HAs of 4 and 6 carbons has been established in S. cerevisiae by the expression of two distinct 
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PHA synthases in yeast peroxisomes. PhaC synthases from C. necator (PhaCCn) and Aeromonas 
caviae (PhaCAc) were modified at the N termini by adding the first 16 amino acids from S. 
cerevisiae peroxisomal 3-ketothiolase protein, which help import foreign proteins into 
perosixome. S. cerevisiae strains deleted in 3-hydroxyacyl-CoA dehydrogenase were employed 
as hosts for SCL-MCL PHA production. To investigate the effect of different mutated 3 
hydroxyacyl-CoA dehydrogenase, fox2Δ cells harbouring PHACCn or PHACAcwere reintroduced 
with wildtype and mutant Fox2. SCL-MCL PHA content significantly increased in fox2Δ cells 
harbouring PHACCn/ PHACAc and mutant Fox2 in domain B (Fox2(bΔ)). Among them, fox2Δ 
cells harbouring PHACCn and Fox2(bΔ) accumulate PHA amount twice as much PHA as fox2Δ 
cells harbouring PHACAc and Fox2(bΔ). However, fox2Δ cells harbouring PHACAc and Fox2(bΔ) 
provided 6 times more 3-hydroxyhexanoic acid than fox2Δ cells harbouring PHACCn and 
Fox2(bΔ).   
Because monomer composition determines favourable properties of PHAs, monomer 
modulation is still a question of great interest in addition to simply PHA content and PHA 
productivity. In one study, modification of the monomer composition of MCL PHA produced in 
S. cerevisiae has been carried out by the manipulation of the enzymes in the β-oxidation pathway 
(Marchesini et al., 2003). Variants of the peroxisomal multifunctional enzyme 2 (MFE-2) have 
been made by mutating A and B domains of the S. cerevisiae 3-hydroxyacyl-CoA 
dehydrogenase. MFE-2(aΔ) mutant having inactivated B domain showed a broad activity 
towards short (C4)-, medium (C10)-, and long (C16)- chain 3R-HA CoAs. Meanwhile, the MFE-
2(bΔ) mutant having an inactivated B domain of the dehydrogenase preferred medium- and long- 
chain 3R-HA CoAs and did not accept short chain-3R-HA CoAs. Different substrates are likely 
to provide various types of PHA monomers including even-numbered, odd-numbered, or a 
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combination of even- and odd- numbered 3R-HAs. It was reported that the pex5 mutant of S. 
cerevisiae grown on C13, C12, C11 and C10 fatty acids accumulated PHA monomers of C13, 
C12, C11 and C10 (approximately 45-77%), respectively (Zhang et al., 2006). Both even- and 
odd- chain PHA monomers were produced in the pex5 mutant when undecanoic acid was used as 
the carbon source. When tetra decanoic acid and decanoic acid were fed in culture, yeast 
accumulated even-chain PHA monomer of C10, C8 and C6. Meanwhile, when tridecanoic acid 
and undecanoic acid were added into media, longer odd-chain monomers of C7 – C13 were 
obtained in yeast cytosol. 
1.8.3 In Plants: Arabidopsis thaliana and Alfalfa (Medicago sativa) 
 In addition to bacteria and yeasts, plants were also considered for being a host of 
biopolymer production due to the fact that plants can produce carbon source and obtain most of 
their energy from sunlight via photosynthesis (Figure 1.6). Acetyl-CoA, which is an essential 
precursor to the PHA production pathway, is widely distributed in plant cells including the 
cytoplasm, plastid, mitochondria and peroxisome (Yunus et al., 2008). It is interesting that there 
has been a wide diversity of plants that were used to study polymer production such as 
Arabidopsis thaliana, Tobacco (Nicotiana tabacum), Rapeseed (Brassica napus), Cotton 
(Gossypium hirsutum), Alfalfa (Medicago sativa), Flax (Linum usitatissimum) and Oil palms 
(Elaeis guineensis and E. oleifera). Discussed in more detail below are two representative plants 
that were selected to demonstrate the ability for polymer production: Arabidopsis thaliana and 
Alfafa (Medicago sativa). The reason is that Arabidopsis is a model plant that has intensively 
been studied, and this plant also was the most successful plant system to produce biopolymer in 
terms of polymer content as well as the variety of polymer types. The second selected plant, 
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Alfafa, was known to have a symbiotic relationship with S. meliloti which is the main host used 
in this study.  
1.7.3.1 Arabidopsis thaliana 
The first plant that was used for PHA production is Arabidopsis thaliana because this 
plant is considered as a model plant to study plant structure and function. The cytoplasm initially 
appears to be the most appropriate subcellular compartment because genes do not need any 
modification to be expressed in this compartment, and one of essential enzymes involved in 
P(3HB) production, 3-ketothiolase, is already present in the cytosol as part of the mevalonate 
pathway. However, expressing two genes phaB and phaC from C. necator in A. thaliana by 
cross-pollination led to only 0.1% of P(3HB) produced in the leaf tissue (Poirier, 2002). 
Interestingly, P(3HB) was found not only in cytoplasm but also in other compartments such as 
the vacuole and nucleus, with the exception of the plastids and mitochondria whose double 
membrane might prevent P(3HB) from penetrating into these sites. The next compartment to be 
targeted for PHA production is the plastid, which provides a high flux of carbon and a closed 
space to separate P(3HB) and protect other cell components. In order to facilitate P(3HB) 
production in this compartment, three genes including phaA, phaB and phaC need to be modified 
at the N-teriminus with the transit peptide from the small subunit of Rubisco under the CaMV35S 
promoter so that these gene products are imported and able to function well within the plastids. 
P(3HB) production in these transgenic plants was shown to be much improved up to 14% DCW 
(Nawrath et al., 1994). However the transgenic plants expressing these plastid-targeted genes 
which were obtained by cross-pollination seem unstable. To counteract this, other groups 
developed a transformation vector that contains all the genes which then can be integrated into 
one single site of the plant genome. This led to P(3HB) accumulation up to 13% and 40% DCW 
34 
 
reported by Valentin et al. (1999) and Bohmert et al. (2000), respectively. The plant growth, 
however, was severely stunted with high P(3HB) accumulation. Analysis of various metabolites 
in plants during P(3HB) accumulation indicated that the TCA cycle was affected, but not the 
fatty acid pool.   
 Arabidopsis was also engineered to produce P(3HB-co-3HV) (Slater et al., 1999; 
Valentin et al., 1999). In order to produce this type of polymer, the plant was transformed with 
four genes: one gene from E. coli (ilvA) and three genes from C. necator (bktB, phbB, phbC). 
The 3-HV precursor was derived from threonine via threonine deaminase and the pyruvate 
dehydrogenase complex. A tool which helps to predict the production of this copolymer in plants 
was constructed and published in 1999 (Daae et al., 1999). The light condition greatly influenced 
the monomer composition as well as the copolymer production rate. Among the enzymes, β-
ketothiolase played a crucial role in controlling the copolymer rate while all the enzymes 
determined the copolymer ratio. β-ketothiolase increased resulting in the increased flux and 
reduced 3HV/3HB ratio in the polymer, while acetoacetyl-CoA reductase and P(3HB) synthase 
increased resulting in the increase of both the flux and the ratio.  
1.7.3.1 Alfalfa (Medicago sativa) 
Alfafa was considered as a host to produce P(3HB) because it was known to generate a 
great deal of biomass for energy uses (Saruul et al., 2002; Yunus et al., 2008). It is a source of 
forage and animal feed. This plant also has a symbiotic relationship with S. meliloti, which is the 
main host used for polymer production in this study. The plant was targeted for the production of 
either P(3HB) or P(3HB-co-3HV) in the leaves by being introduced to three plastid-targeting 
genes involved in P(3HB) synthesis (phbA, phbB, phbC) or P(3HB-co-3HV) synthesis (bktB, 
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phbB, phbC). However, the P(3HB) content was extremely low and fluctuating from 0.025 to 1.8 
g/kg DCW. Moreover, P(3HB-co-3HV) was unable to be obtained in this plant due to 
insufficient flux of substrates to synthesize β-ketoval-CoA. Instead, only P(3HB) was obtained in 
the transgenic plant which carries the bktB, phbB, phbC genes with a lower amount compared to 
the plant carrying phbA, phbB, phbC. Therefore, the P(3HB) amount was dependent on which 
specific β-ketothiolase gene (phbA or bktB) was used. The only bright side was that there was no 
issue related to stunted growth. Additionally, similar P(3HB) amount was observed between F1 
hybrid progeny and parental line suggesting that polymer production in alfafa was a stable and 
dominantly inherited trait.  
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Figure 1.6 Modification of plant metabolic pathways for the synthesis of medium-chain-length 
polyhydroxyalkanoate (MCL-PHA) in the peroxisomes of plants (Adapted from Poirier, 2002) 
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1.9 Advanced applications of PHA  
 PHAs are not only biodegradable materials which may replace petroleum-derived plastics 
but they also be employed for advanced applications in medical and biological fields. 
Biocompatibility is one of the most important properties for the materials to be considered for 
health-related applications such as implantation and drug carriers. Since side effects might lead 
to lethal consequences when using traditional materials, such as silicone and synthetics to 
construct artificial human tissue, it is desirable to discover materials having a good quality as 
well as available biocompatibility (Jung et al., 2010a). Therefore, PHA has been found to be a 
preferable choice in tissue engineering including scaffold development (Park et al., 2005a). 
Blends of hydroxyapatite (HAP) and P(3HB)/P(3HB-co-3HHx) were evaluated in the application 
of making scaffold for bone reconstruction. It was interesting that different effects on mechanical 
properties of scaffolds and osteoblast response were obtained when HAP was incorporated into 
different kinds of PHA; incorporation of HAP into P(3HB) improved osteoblast response, while 
its incorporation into P(3HB-co-3HHx) had an adverse effect (Wang et al., 2005). Likewise, 
different effects on the cell were also observed in scaffold development depending on the 
specific blend of PHAs. Chondrocytes grew and proliferated best on PHAs that were made from 
the blend of P(3HB-co-HHx) and P(3HB) at the ration of 6:4 (Zhao et al., 2003). 
  In addition to scaffolds in tissue engineering, PHAs have been used in various medical 
fields, such as vascular grafts, stents, patches, sutures and drug carriers. In particular, P(3HB) 
micropheres were employed for sustained drug release. However, it takes longer for P(3HB) to 
degrade in the body compared to other commercial polymers, such as polyglycolide (PGA), due 
to its high crystallinity. Therefore, an alternative material with more flexibility and less 
crystallinity, P(3HB-co-3HV), has been taken into consideration for applications related to drug 
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carriers in microspheres and implants. P(3HB-co-3HV)-coated microspheres and microcapsules 
were designed to contain tetracycline and examined for encapsulation efficiency, loading, release 
characteristics, and morphological properties (Sendil et al., 1999). To improve the encapsulation 
efficiency and prolong the release period, it was neutralized with NaOH. Biodegradability was 
not an issue in the release behavior because the release process was completed much before than 
the beginning of polymer degradation. In addition, implantation of antibiotic-loaded rods of 
P(3HB-co-3HV) for the treatment of chronic osteomyelitis was examined by introducing the rods 
into a rabbit tibia artificially infected by Staphylococcus aureus, and complete recovery was 
observed in 30 days (Yagmurlu et al., 1999).  
 PHAs were also applied in immunoassays based on the substrate specificity of PHA 
depolymerase (Lee et al., 2005). In this study, two model detectable proteins were used including 
enhanced green fluorescent protein (EGFP) from Aequorea victoria and red fluorescent protein 
(RFP) from Discosoma. At the C-terminus, EGFP or RFP was fused to the substrate-binding 
domain (SBD), a part of PHA depolymerase used to recognize PHA and bind to it. At the N-
terminus, model proteins were tagged with a hexahistidine for downstream purification using Ni 
columns. The mean fluorescence from protein-binding PHA microbeads was 3-fold higher than 
the negative control. This indicated that both specific protein-binding interaction and post-
binding biologically active fusion proteins were achieved. For an example of a practical 
application, this approach has been employed to design an immunoassay system for severe acute 
respiratory syndrome (SARS) virus detection. A fusion protein composed of the SARS 
coronavirus (SARS-CoV) envelope protein (SCVe) and SBD was constructed and produced in 
recombinant E. coli. This fusion protein was used to raise the anti-SCVe rabbit polyclonal 
antibody. Then the fusion protein was incubated with PHB-coated microbeads which 
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subsequently came in contact with anti-SCVe antibodies. After the unbound protein was washed 
away, the binding event was determined using flow cytometry. As expected, the results 
demonstrated that the fluorescence signal was detected only when the binding event occurred. 
The follow-up study examined the application of using PHA-coated slides to detect the hepatitis 
B virus (HBV) preS2 surface protein and SCVe (Park et al., 2006). Likewise, the single-chain 
antibody (ScFv) against HBV protein and SCVe were fused to SBD before being fixed on PHA-
coated slides via microspotting. Fluorescence was only detected upon specific antigen-antibody 
interaction, indicating that this technique can be considered as a useful method in immunoassay 
with a high degree of affinity and selectivity.  
 Another study demonstrated PHA synthases can be used as molecular tools to recycle 
biocatalysts by covalently immobilizing the enzyme at the PHA granule surface. The β-
galactosidase (LacZ) was fused to the N-terminus of PHA synthase (PhaC1) from P. aeruginosa 
via a linker region. By introducing the open reading frame of lacZ-phaC1, P. aeruginosa PHA-
negative mutant strain could restore the ability of PHA biosynthesis, showing a PHA synthase 
activity from the fusion protein. The surface of PHA granules retained more LacZ-PhaC1 fusion 
proteins than PhaC1 alone. The treatment of these LacZ-PHA granules with urea suggested a 
covalent binding of the LacZ-PhaC1 fusion protein to the PHA granule. Moreover, the 
immobilized LacZ remained stable for several months under various storage conditions, with its 
own activity. Therefore, a powerful platform for efficient in vivo enzyme immobilization was 
developed by using PHA and engineered PHA synthase (Peters and Rehm, 2006). 
 Application of PHAs has also been used in water and wastewater treatment, specifically 
the denitrification step (Hiraishi and Khan, 2003). Traditionally, in order to remove nitrogen, 
either organic matter or simple organic compounds (e.g., acetate and methanol) were used as 
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electron donors in the system. However, both of them had their own drawbacks that required 
some alternative solution to replace this conventional system. Researchers developed the solid-
phase denitrification process using PHAs and related biodegradable polymers as a constant 
sources of reducing power since PHAs easily degraded in the system. Additionally PHAs are 
insoluble in water, hence they can also serve as solid matrices for biofilm development which 
help control the process rate.  
 A new trend of PHA applications is the production of PHA-derived biofuels (Zhang et 
al., 2009). SCL and MCL PHAs were cleaved and converted into methyl esters (ME) via the 
methanolysis reaction.  The entire process is quite straight-forward and feasible in a single 
fermenter as shown in Figure 1.7. Combustion heat generated from 3HBME and 3HAME were 
20 and 30 kJ/g, respectively, while ethanol generated a combustion heat of 27 kJ/g. Interestingly, 
the combustion heat of ethanol could be increased up to 30 and 35 kJ/g by adding 10% 3HBME 
or 3HAME. The cost to produce PHA-derived biofuel was roughly estimated around US$1200.  
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Figure 1.7 Schematic illustration of production PHA-based biofuels (Adapted from Zhang et al., 
2009)  
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1.10 Objectives of this study 
This study aimed to engineer bacterial strains so that they are able to produce a broad 
range of bioplastic polymers such as PLA, P(3HB-co-LA), and P(3HB-3HHx-3HO-LA) with 
different properties for various applications. The primary rationale for choosing S. meliloti and P. 
putida strains is that these strains are native SCL and MCL PHA producers, respectively, and 
they are also genetically amenable. In both cases, complete genome sequences are available, and 
the PHA synthesis genes are known. Also these strains are able to use a broad range of 
substrates. For example, P. putida is able to use both fatty acids and sugars to produce MCL 
PHAs. The strains also can grow rapidly, reach high titre, and are able to readily accumulate 
polymer granules.  
For novel polymer production, recent studies have mostly focused on engineering E. coli 
strains that are common model systems in the metabolic engineering field. E. coli strains have 
been engineered to produce a broad range of bioproducts such as biopolymers, biofuels, amino 
acids, and succinic acid because their molecular tools are intensively studied and widely 
available. However, E. coli strains are not native polymer producers; hence, they lack the system 
for the production of usable polymer precursors. Also, it was shown that E. coli strains suffer 
from the stress of polymer production, and they produce some side products that might decrease 
the overall yield of target products. For these reasons, we focused our study on engineering these 
two representative native polymer producers for an efficient novel polymer production system. 
Our approach is to introduce two codon-optimized engineered genes encoding propionate CoA 
transferase (pct) and PhaC synthase (phaC) into the aforementioned hosts. Based on previous 
studies, the novel polymer P(3HB-co-LA) was able to be produced in E. coli, a non-native 
producer by introducing these two engineered enzymes (Jung et al., 2010b). The pct gene was 
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engineered to accept lactate as a substrate and convert it into (D)-lactyl-CoA in the cell, while 
the phaC gene was engineered to broaden the substrate specificity toward SCL, PHA and lactate. 
For the S. meliloti host, two strategies were outlined; one involved integrating the genes 
into the chromosome and expressing them under the native phbC promoter, or so-called 
chromosome-engineering; the other is putting the genes in an expression vector and expressing 
them under an inducible tac promoter. The advantages of the first strategy are that the genes 
remain more stable and fixed on the chromosome with less risk of being lost during production; 
also, putting them under native promoter should result in expression of the genes in a manner 
similar to the expression of the native phbC gene. The advantages of the second strategy are that 
the genes can be expressed under a tunable promoter; moreover, this system is more flexible and 
can be easily introduced into different hosts for a broader range of application in term of the 
types as well as the properties of the produced polymer. For P. putida host, the initial 
investigation was carried out when the genes were expressed on the plasmid-based form. As 
mentioned earlier, the plasmid-based system is very flexible; therefore, transferring this system 
into P. putida can be done easily in a short period of time. Another aspect to explore is promoter 
engineering which involves replacing the inducible promoter with a broad range of native 
promoters of different strength.  
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Chapter 2 Material and methods 
2.1 Bacteria, primers and growth conditions 
2.1.1 Bacteria and primers used 
 All strains and plasmids used in this study are listed in Table 2.1. The strains were stored 
at -80ºC in Tryptone Yeast extract broth with 7% DMSO.  
2.1.2 Media and growth condition 
 E. coli and P. putida were routinely cultured in Luria-Bertani (LB) media while S. 
meliloti was cultured in Tryptone Yeast (TY) media, supplemented with appropriate antibiotics 
as necessary for plasmid maintenance (Charles and Finan, 1990; Charles and Finan, 1991). 
Suicide plasmid pK19pctPhaC was maintained in E. coli using Km (25 µg/mL). Expression 
plasmid pTH1227 and its derivatives were maintained in all strains using tetracycline (10 
µg/mL). The recipes of all media can be found in the Appendix.  
 For polymer production in S. meliloti, strains were initially inoculated in TY broth, and 
then 1% overnight culture was transferred to Yeast Extract Mannitol (YEM) media in flasks on a 
shaker at 180 rpm, 30C for 3 days. IPTG at 0.4 mM was added into the culture for induction, 
unless otherwise stated. Rapid screening of polymer production was performed by adding Nile 
Red (0.5 µg/mL) to YM agar plate, and observing its mucoid phenotype or visualizing by 
fluorescence (Heil et al., 2011).  
 For polymer production in P. putida, strains were initially inoculated in LB broth, and 
then 1% overnight culture was transferred to either LB or defined media (0.5E2) in flasks on a 
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shaker at 180 rpm, 30°C for 3 days. Nile Red (0.5 µg/mL) was added to LB or 0.5E2 agar plate 
for rapid screening of polymer production. 
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Table 2.1 List of strains that were used in this study 
Strains or plasmids Genotype Reference 
E. coli    
DH5α  supE44 lacU169(w80lacZDM15) hsdR17 recA1 endA1 
gyrA96 thi-1 relA1 
(MacLellan et al., 
2006) 
DH5α(pRK600) Helper strain harbouring plasmid pRK600 (Finan et al., 1986) 
S. meliloti    
Rm1021 Spontaneous Sm isolate of R. meliloti SU47 (MacLellan et al., 
2006) 
Rm11144 Rm1021 phaC1::Tn5-233 (Charles et al., 1997) 
Rm7055 Rm1021 exoF:: Tn5 (Leigh et al., 1985) 
SmUW499 Rm1021 ΔphaC exoF:: Tn5 Ricardo Nordeste 
SmUW501 Rm1021 ΔphaAB ΔphaC exoF:: Tn5 Ricardo Nordeste 
SmUW254 Rm1021 phaC1::pct PhaC This study 
SmUW255 SmUW499 harbouring pTH1227 This study 
SmUW256 SmUW499 harbouring pTAM This study 
SmUW257 Rm7055 harbouring pTH1227 This study 
SmUW498 Rm1021 ΔphaAB exoF:: Tn5 Ricardo Nordeste 
SmUW502 Rm1021 ΔphaAB ΔphaZ exoF:: Tn5 Ricardo Nordeste 
SmUW503 Rm1021 ΔphaC ΔphaZ exoF:: Tn5 Ricardo Nordeste 
SmUW500 Rm1021 ΔphaAB ΔphaC exoF:: Tn5 Ricardo Nordeste 
SmUW550 Rm1021 phaAB exoF:: Tn5 harbouring pTH1227 This study 
SmUW551 Rm1021 phaAB exoF:: Tn5  harbouring pTAM This study 
SmUW552 Rm1021 phaAB phaZ exoF:: Tn5 harbouring pTH1227 This study 
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SmUW553 Rm1021 phaAB phaZ exoF:: Tn5 harbouring pTAM This study 
SmUW554 Rm1021 phaC phaZ exoF:: Tn5 harbouring pTH1227 This study 
SmUW555 Rm1021 phaC phaZ exoF:: Tn5 harbouring pTAM This study 
SmUW556 Rm1021 phaZ exoF:: Tn5 harbouring pTH1227 This study 
SmUW557 Rm1021 phaZ exoF:: Tn5 harbouring pTAM This study 
SmUW558 Rm1021 phaAB phaC exoF:: Tn5 harbouring pTH1227 This study 
SmUW559 Rm1021 phaAB phaC exoF:: Tn5 harbouring pTAM This study 
SmUW560 SmUW499 harbouring pTAM2 This study 
SmUW561 SmUW499 harbouring pTAM3 This study 
SmUW562 SmUW499 harbouring pTAM4 This study 
SmUW563 SmUW499 harbouring pTAM5 This study 
SmUW564 SmUW499 harbouring pTAM6 This study 
SmUW565 SmUW499 harbouring pTAM7 This study 
SmUW567 SmUW499 harbouring pTAM2noinsert This study 
SmUW568 SmUW499 harbouring pTAM6noinsert This study 
SmUW569 SmUW499 harbouring pTAM7noinsert This study 
P. putida 
PPUW1 
 
P. putida KT2440 (Rif
r
) 
 
(Le Meur et al., 2012) 
PPUW2 ΔphaC1-phaZ-phaC2/ ΩKm in PPUW1(Kmr)  Jiujun Cheng 
PPUW18 
PPUW19 
PPUW2 harbouring pTH1227 
PPUW2 harbouring pTAM 
This study 
This study 
PPUW20 PPUW1 harbouring pTH1227 This study 
PPUW21 PPUW1 harbouring pTAM This study 
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Table 2.2 List of plasmids and primers that were used in this study 
Plasmids Description Reference 
pRK600 pRK2013 npt::Tn9 Cm
r
 Nm-Km
s 
(Finan et al., 1986) 
pTH1227 pFUS1 carrying lacI
q
-Ptac DNA from pMal-c2x 
(AB32193/AB32194), Tc
r
 
(Cheng et al., 2007) 
pTAM pTH1227 pct532 phaC1400 (codon-optimized) This study 
pK19mobsacB suicide plasmid mobilizable (oriT, oriV) sacB lacZα, Kmr (Schäfer et al., 1994) 
pK19pctphaC pK19mobsacB derivatives carrying pctphaC fragment  This study 
pTAM2 pTAM derivative, P0 promoter- a substitute for lacI
q
-Ptac  This study 
pTAM3 pTAM derivative, P1 promoter- a substitute for lacI
q
-Ptac This study 
pTAM4 pTAM derivative, P2 promoter- a substitute for lacI
q
-Ptac This study 
pTAM5 pTAM derivative, P3 promoter- a substitute for lacI
q
-Ptac This study 
pTAM6 pTAM derivative, P4 promoter- a substitute for lacI
q
-Ptac This study 
pTAM7 pTAM derivative, P5 promoter- a substitute for lacI
q
-Ptac This study 
pTAM2- 
nopctphaC 
pTAM2 derivative, removal of pctPhaC fragment This study 
pTAM6- 
nopctphaC 
pTAM6 derivative, removal of pctPhaC fragment This study 
pTAM7- 
nopctphaC 
pTAM7 derivative, removal of pctPhaC fragment This study 
pUC57pctphaC pUC57 harbouring two genes, pct and phaC  This study 
pSRKGm pBBR1MCS-5-derived broad-host-range expression vector 
containing lac promoter and lacI
q
, lacZα+, and Gmr 
(Khan et al., 2008) 
pSRKldhA pSRKGm carrying ldhA gene from E. coli This study 
pSRKldhAacs pSRKldhA carrying acs  gene from E. coli This study 
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pSRKSfacs pSRKGm carrying acs gene from S. fredii    This study 
pSRKglcDacs pSRKSfacs carrying  glcD gene from S. fredii This study 
pJetEcacs pJet carring acs  gene from E. coli This study 
pTH1227a DH5α harbouring   This study 
pTH1227b DH5α harbouring  pTH1227b This study 
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Table 2.3 List of native promoters, their sequences and original genes which were expressed 
under these promoters in S. meliloti 
Promoter 
name 
Promoter sequence Genes 
involved 
P0 
 
P1 
 
P2 
 
P3 
 
P4 
 
P5 
5’-aagcttTCTAGAGTTGACAGGACGAATGCAGGCGGTCAT 
ATACCCGGCGCAGActcgag-3’ 
5’-ctagaAGATCTGTTGACACGATTGGGTCGACACGGTATG 
TGCCTGCCTACTTc-3’ 
5’-ctagaAGATCTCTTGTTATCCCGCAGACCTTCATGTATAG Gc-3’ 
5’-ctagaAGATCTCTTGTGGTTTTCGCAATCGGTCTTTATGTA 
GGGTCCAAACAc-3’ 
5’-ctagaAGATCTCTTGACGGGATGAAAAATTCTGGGAATCAC 
CATTTCAAGCAc-3’ 
5’-ctagaAGATCTCTTGAGATTCCTCATTTCCTGATCAATTTC 
GGGTCAACCGGc-3’  
smc1378 
 
rpmJ 
 
rpmE 
 
secE 
 
rpoD 
 
ropB1 
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2.2  DNA manipulation 
2.2.1 Plasmid isolation 
 Plasmid minipreps from E. coli were carried out using an alkaline lysis method 
(Birnboim and Doly, 1979). All the components in all solutions can be found in the Appendix. 
The cell pellet of 3-5 ml overnight culture was harvested by centrifuging at 13,000 rpm, 30 sec. 
Then the cell pellet was re-suspended in 250 µl of resuspension solution I, followed by adding 
250 µl lysis solution II and inverting the tubes several times to lyse the cell membrane and 
release DNA and protein into the solution. The next step is to precipitate out proteins and 
chromosome DNA by adding 350 µl of neutralization solution III, inverting the tubes and 
centrifuging at 13,000 rpm, 5 min. Now the precipitates settle at the bottom of the tubes, and the 
lysate can be removed by pipetting and transferred to the commercial BioBasic silica spin 
columns. Subsequently, plasmid DNA can be collected on the column by centrifuging these 
columns and removing the liquid passing through. The following step is the washing step by 
adding 500 µl of washing buffer into the column and centrifuging the column again. Trace 
amount of ethanol in washing buffer can be completely removed to avoid interfering the 
subsequent enzyme reaction by centrifuging the column once again. DNA plasmid can be eluted 
in 50 µl of elution buffer. 
2.2.2 Genomic isolation 
 This method was adapted from a previous study (Meade et al., 1982). A 5-ml volume of 
culture was harvested by centrifuging at 13,000 rpm, 1 min. Then the liquid was discarded. The 
cell pellet was resuspended in 500 µl TES (10 mM Tris, 25 mM EDTA, pH 8.0) and then lysed 
by the addition of lysis solution which was composed of 20 µl of 25% SDS, 50 µl of 5mg/ml of 
predigested Pronase E and 50 µl of 5 M NaCl. The lysis occurred at 68C, 30 min, followed by 
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the addition of 260 µl of 7.5 M ammonium acetate. Proteins were precipitated out when the 
mixture was left on ice for 20 min. Proteins were then removed by centrifuging at 13,000 rpm for 
15 mins. DNA was extracted using chloroform in a ratio 1:1 after the tubes were inverted several 
times. Liquid on the top phase was transferred to a new tube containing 780 µl of isopropanol. 
The tubes were incubated on ice for 30 min to precipitate DNA. DNA was pelleted at the bottom 
of the tube by centrifuging 13,000 rpm, 15 min and removing the supernatant. The DNA pellet 
was washed with 500 µl of 70% ethanol before centrifuging at 13,000 rpm for 1 min. After the 
supernatant was discarded, DNA was dissolved in 50 µl of T10E1 buffer. 
2.2.3 Enzyme digestion 
 DNA was digested using the appropriate enzymes (Thermo Scientific). The reaction mix 
are composed of samples, 0.5 µl of the appropriate enzymes and 1X Fast Digest reaction buffer 
in a total volume of 10 µl. This mixture was then incubated at 37C, 30 mins.  
2.2.4 Dephosphorylation of vector DNA 
 To prevent the backbone vector from re-circularizing, dephosphorylation was carried out 
using Fermentas shrimp alkaline phosphatase (SAP). The reaction mixture consisted of the 
digested vector, 1X reaction buffer and SAP. The mixture was then incubated at 37ºC, 10 min 
followed by the inactivation of SAP at 65C, 5 min.  
2.2.5 Ligation 
 The molar ratio of the backbone to the insert was normally 1:3. Then 0.5 µl of ligase and 
1X ligase buffer were added into the mixture, followed by overnight incubation at 16C. 
Negative control was always included, which contained sterile DW instead of the insert. 
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2.2.6 Agarose gel electrophoresis 
 0.8% agarose gel was made in 1X TAE buffer and casted on the tray. Samples were 
loaded into the wells and ran at 110V for roughly 50 min. Fermentas Generuler 1 kb DNA ladder 
was also run along with samples. DNA was visualized using a UV box composed of a dual 
intensity UV transilluminator and a camera connected to a computer. 
2.2.7 Gel purification 
 Samples were loaded and run on 0.8% agarose gel for 1 hr. By being visualized under 
UV, the desired band was then cut out and weighted. Then the gel was dissolved in 3 volumes of 
binding buffer II by being incubated at 65ºC for 5 min or until the gel was dissolved completely. 
The tubes were inverted several times to mix the solution, and the solution was subsequently 
loaded onto commercial Biobasic silica spin columns and centrifuged at 13,000 rpm for 1 min. 
The flow-through was discarded, while the DNA samples were remained on the filters of the 
columns. And these columns were washed with 500 µl of the washing buffer and dried by 
centrifuge. 50 µl of elution was the added into the column to elute DNA into a new 
microcentrifuge tube. 
2.2.8 High-fidelity PCR 
To amplify and clone desired genes, the high-fidelity polymerase KOD Hotstart, 
purchased from Novagen, was used to minimize amplification errors. The total reaction volume 
was normally 50 µl including 1 µl of template (10-100 ng/µl) , 1.5 µl of 100 µM each primer 
(forward and reverse), 5 µl of 2 mM dNTP, 25 µl of 2X Xtreme buffer, 1 µl of KOD and water 
topped up to 50 µl.  
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PCR was set following the normal procedure: Initialization step: 94C for 2 min (1 
cycle); Denature step: 94C for 20-30 sec, Annealing step: temperature was adjusted according 
to used primers (normally 5C lower than melting temperature) for 30 sec, Elongation step: 68C 
(time depending on the length of amplified DNA with the rate of 1 kb/min) (these three step 
were repeated for 25-30 cycles); Final elongation: 68C for 5 min (1cycle); Final hold: 4C. 
2.2.9 Colony PCR 
To confirm the presence of target DNA, colony PCR was performed using either PCR 
master mix purchased from Thermo Scientific or home-made Taq polymerase.  
For Taq polymerase, the reaction mixture included 1 µl of 100 µM each primer (forward 
and reverse), dNTP, 0.5 µl of Taq polymerase, 2 µl of 10X Taq buffer, 2 µl of 25 mM MgCl2 
(optional), DMSO (optional if DNA was GC-rich) and water topped up to 20 µl. If there were 
multiple reactions of the same type, the Master mix was prepared before aliquoting into PCR 
tubes.  
For PCR master mix, all components were supplied in the mix purchased from Thermo 
Scientific. Primers were added into the mix with the same amount as previously mentioned. 
Template is the colony picked up by yellow tips and mixed in the reaction mixture. 
Colony PCR was carried out using the normal PCR protocol or touch-down protocol. The 
normal PCR is similar to the high-fidelity PCR protocol except for initialization step (95C, 3-
5min) and elongation (72C). Touch-down protocol was set as following: Initialization step 
95C, 3-5min (1cycle), Denature step: 94C for 20-30 sec, Annealing step: temperature was  set 
at the initial temperature 70C and decreased 0.5C for every subsequent cycle, 30 sec for each 
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cycle, Elongation step: 72C (time depending on the length of amplified DNA with the rate of 1 
kb/min) (these three step were repeated for 25-30 cycles); Final elongation: 68C for 5 min 
(1cycle); Final hold: 4C. 
2.3 DNA transferring 
2.3.1 Heat-shock transformation 
E. coli strain DH5α was used for cloning throughout the project. Heat-shock 
transformation was first carried out by adding ligation mix into competent cells. Then the 
competent cell mixture was left sitting on ice for 30 min before moving to the heat block at 42ºC 
for 90 sec. After doing heat-shock transformation at 42ºC to transfer DNA into the cells, the 
mixture stayed in ice for 5 min. Subsequently, 1 ml LB was added into the mixture which would 
be cultivated at 37ºC for 1 h to recover DNA-containing cells. Transformants were selected on 
LB plates containing the appropriate antibiotics. 
2.3.2 Conjugation 
1 ml of recipient, helper and donor strains were spun down using centrifuge at 13000 
rpm, 30 sec. 500 µl of saline (5% NaCl) was then used to wash these cell pellets twice. 
Recipient, helper and donor strains were then re-suspended in saline and mixed together in the 
ration of 2:1:2. Then the mixture was spotted on TY media and incubated at 30ºC, overnight. 
These mating spots were subsequently streaked on selection plates using the appropriate 
antibiotics. 
2.3.3 Transduction 
The lysate was diluted in 1/20 or 1/50 before 1 ml of diluted lysate was mixed with 1 ml 
of the recipient culture. The mixture was kept at room temperature for 20 mins. The cell were 
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pelleted and washed twice with saline by centrifuging at 13,000 rpm, 30 secs, followed by being 
re-suspended in saline. The cell mixture was then plated on LB with the appropriate antibiotics 
and incubated at 30ºC. 
2.4 RNA work 
2.4.1 RNA isolation 
RNases are present everywhere and very active, hence extra care must be taken to avoid 
sample degradation by using gloves and RNase-free materials. All solutions are prepared in 
RNase-free water or DEPC-treated water. Cells were sub-cultured in TY and grown to OD = 0.5 
– 0.8. Stop solution which is 5% phenol in ethanol was added into the culture and mixed well to 
stop the cell growth. Next, culture was harvested by centrifuging at 5,000 rpm, 4C for 10 min. 
Cells can be stored at -70C after flash freezing in liquid nitrogen.  
 RNA extraction was performed following the hot phenol extraction protocol with some 
modification (Lin-Chao and Bremer, 1986). All the following steps should be carried out at 4C, 
unless otherwise stated. The cell pellet from a 50 ml culture was thawed on ice and re-suspended 
in 960 µl of RNase-free water by vortexing. Next, 480 µl of hot phenol solution was added to an 
equal volume of cell re-suspension, vortexed vigorously and incubated in a water bath at 95C 
for 1 min. The sample was spun down at 13000 rpm, 4C for 10 min. Supernatant was added to 
600 µl phenol/chloroform, and vortexed vigorously. Then, it was spun again for 5 mins, and 
aqueous phase was extracted twice with chloroform. To precipitate nucleic acid, the aqueous 
phase was added to 1/10 volume of sodium acetate and 2 volume of isopropyl alcohol, inverted 
to mix and incubated on ice for 30 min. Next, the sample was spun for 10min, washed with -
20ºC 70% ethanol and air-dried until the pellet turned translucent. Precipitate was then 
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resuspended in 85 µl water and digested with 5 µl DNase I in 10 µl DNase I buffer at 37C for 
30 min to remove DNA from the sample. The DNA-free sample was confirmed by running on an 
agarose gel. If DNA is still present in the sample, water was added into the sample up to the 
volume of 400 µl, and nucleic acid precipitation was repeated as described above, followed by 
another round of DNA digestion. The RNA sample was further purified using Qiagen RNeasy 
mini kit, and finally resuspended in 100 µl water. The quantification of RNA was determined 
using the Nanodrop, and the ratio of A260/A280 should be around 2.0. The quality of RNA was 
checked by imaging the agarose-formaldehyde gel to observe rRNA bands. 
2.4.2 Dot blot 
Samples with equal amount of RNA were applied onto a positively charged membrane 
using the Bio-Dot Microfiltration Apparatus (Bio-Rad). The membrane was placed on the gasket 
and wetted with 2x SSC. Saran wrap was used to cover unused wells. RNA samples were blotted 
to each well, followed by washing with 200 µl TE. Vacuum was used to help liquid pass through 
the membrane. Membrane fixation was performed using the UV-crosslinker instrument, using C-
L program. Prehybridization was performed in DIG Easy Hyb buffer (Roche) at 40ºC for 30-45 
min, followed by hybridization overnight at the same temperature. Washing and detection steps 
were carried out as outlined in the manufacturer's protocol for the DIG High Prime DNA 
Labeling and Detection Starter Kit II (Roche).  
2.5 Enzyme-related works 
2.5.1  β-glucuronidase activity assay 
This assay was carried out following the procedure as previously described (Russell and 
Klaenhammer, 2001). Cells were fully grown in TY media, and then the culture was added into 
the assay buffer at the ratio of 1:4, incubating at room temperature until the mixture turned into a 
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yellow color, at which point sodium carbonate was added to terminate the reaction. Reaction 
time and the absorbance of the mixture at 420 nm were recorded. Cell density of the culture was 
measured at 600nm for normalization.  
2.6 Cell disruption methods 
2.6.1 Bead-beater 
5 ml of culture was harvested by centrifuging at 13,000 rpm, 30 sec. Then the cell were 
washed with 1 ml of lysis buffer and harvested again. The supernatant was discarded, while the 
cells were resuspended in 500 µl sonication buffer. Roughly 350 µl of 0.1 mm silica beads was 
added to the resuspended cells. The cells were then disrupted using a BioSpecs Products 
minibead-beater for 8 rounds of 30 sec pulse and 30 sec rest. After bead-beating, the supernatant 
was transferred to a new microfuge tube and centrifuged to remove cell debris and beads. 
2.6.2 Sonication 
5 ml of culture was harvested by centrifuging at 13,000 rpm, 30 sec. Then the cells were 
washed with 1ml of lysis buffer and harvested again. The supernatant was discarded, while the 
cells were resuspended in 500 µl sonication buffer. The cell mixture was then sonicated in 30 sec 
pulse and 30 sec rest on ice for 6 rounds (the Microson™ ultrasonic cell disruptor was set 13,000 
– 14,000 watt). The ultrasonic probe was cleaned with 70% ethanol for every new run. After 
sonication, the supernatant was transferred to a new microfuge tube and centrifuged to remove 
cell debris. 
2.6.3 Bradford assay 
Bradford assays were done to measure the protein concentration in the samples which 
were then used to normalize values from enzyme assays. 1 ml of cell culture was harvested by 
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centrifuging at 13,000 rpm, 1 min and then re-suspended in 500 µl of 0.25M NaOH. The tube 
was incubated in a heat block at 100ºC for 5 min. 500 µl of 0.5M HCl was added to the tube 
followed by vortexing. The sample was subsequently centrifuged at 13,000 rpm for 1 min at 4C. 
10 µl of supernatant was removed and added to 90 µl of Bradford reagent. The mixture was 
mixed well before the absorbance at 595 nm was taken. The standard curve was also constructed 
every time that this assay was carried out by mixing 10 µl of standard BSA of various 
concentrations (0, 50, 100, 200, 300, 400, 600, 800 and 1000 µg/ml) with 90 µl of Bradford 
reagent and measuring the absorbance at 595 nm.  
2.6.4 SDS PAGE and His-tag staining 
To detect the expression of His-tagged proteins, S. meliloti strains were subcultured in 
TY at 30°C starting at OD600 of 0.1, followed by adding IPTG to 0.4 mM when OD600 reached 
0.4 and incubating at room temperature overnight for expression. Approximately 5 ml of 
overnight culture was harvested by centrifuging at 17,000 g for 1 min. The pellet was 
resuspended in 10 µl loading dye and 40 µl distilled water before incubation at 95C for 5 min to 
lyse the cells. The mixture was then centrifuged at 17,000 g for 1 min to remove cell debris. 
Then 10 µl of sample was loaded onto a 8% polyacrylamide gel and run at 200 V for 1 h using 
the Bio-Rad Power Pac 3000 apparatus. Finally, the gel was used for His-tag staining following 
the InVision™ His-tag In-Gel Stain protocol provided by Invitrogen.  
2.7 Polymer-related work 
2.7.1 Gas chromatography (GC) 
Intracellular polymer production was evaluated by gas chromatography following a 
protocol which has been described by others (Braunegg et al., 1978; Jung et al., 2009). Briefly, 
cells were harvested from flask culture after a 3-day incubation by centrifuging at 4,000 g for 20 
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min, then washed twice with distilled water, and finally dried at 100C overnight. The dried cell 
weight (DCW) was recorded before methanolysis in 2 ml chloroform and 1 ml PHA solution 
containing 8 g benzoic acid l
-1
 as an internal standard and either 30% sulfuric acid (for SCL 
PHA, PLA or P(3HB-co-LA) analysis) or 15% sulfuric acid (for MCL PHA) in methanol. The 
reaction was carried out at 96C for 6 h, cooled, and then 1 ml of water was added, the mixture 
was vortexed, and the solution was allowed to separate into two phases. 1 µl of the chloroform 
phase was taken for analysis by GC as previously described (Jung et al., 2009).  The samples 
were injected into Agilent 6890 series GC system with a DB Wax column (30 m x 0.53 mm, film 
thickness 1 µM, J & W Scientifics), which is located in the Department of Chemical 
Engineering. The oven program was set as following: initial temperature was set at 80ºC for 5 
min, then ramped to 230ºC at 7.5ºC/min, and continued to ramp to 260ºC at a faster rate 
10ºC/min followed by maintaining that temperature for 5 min. 
2.7.2 Gas chromatography/ Mass spectrometry (GC/MS) 
The samples analyzed using GC/MS were prepared similar to those analyzed using GC as 
described earlier. The samples were injected into Agilent Technologies 6890N Network GC 
system with MS detector (inert XL EI/CI MSD 5975B, Agilent Technologies) and capillary HP-
5MS 5% Phenyl Methyl Siloxane column (30m x 0.25 mm, film thickness 0.25 µM, Agilent 
19091S-433) located in the Department of Chemistry . The oven program was set as following: 
initial temperature was set 50ºC for 5 min, then ramped to 280ºC at 20ºC/min, and held for 10 
min. 
2.7.3 Nuclear magnetic Resonance (NMR) 
NMR experiments were performed using Bruker 500MHz UltraShield
TM
 spectrometer 
following the protocol as described previously (Jung et al., 2010b). A proton with 16 scans was 
61 
 
run and integrated to show how much H there was (for example CH2 should integrate to 2 
protons). Then a gs-COSY (COrrelation SpectroscopY) was performed to see which protons are 
coupled to each other, using gradient pulses. The next experiment was HMQC (Hetronuclear 
Multiple Quantum Correlation) which indicated which protons are attached to which carbons.  
There must be C-H connection to observe this. Also, HMBC (Hetronuclear Multiple Bond 
Correlation) was carried out to show the long range H,C correlations via 2 J(C-H) and 3J(C-H) 
i.e.,2; to 3 bond coupling.  This method suppresses the 1J C-H coupling and shows how carbons 
with no protons are connected. Finally, 3 carbon experiments were run; including 2 dept 
experiments (dept 135 showed which carbons are CH3, CH2, CH, and the dept 90 indicates which 
carbon is CH only) and a standard experiment that reveals where the carbons are in ppm and 
indicated all the Carbons with and without protons attached. 
2.7.4 Polymer extraction 
1 L of culture, cultivated in YEM media for 3 days, was harvested and washed twice with 
de-ionized water. The cell pellet was subsequently freeze-dried for 6 h. After being freeze-dried, 
the polymer was extracted in 10 ml chloroform using reflux apparatus for 4 h. Next, cell debris 
was removed by passing through a filter (number 1 Whatman). Eventually, the polymer was 
precipitated using 100 ml cold methanol, and the solvent was evaporated by drying in a 
fumehood overnight. This process was repeated to extract any leftover polymer in the cells. The 
process was performed as shown in Figure 2.1. 
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Figure 2.1 Polymer purification and analysis process. 
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Chapter 3 Chromosome-engineering in 
Sinorhizobium meliloti  
3.1 Introduction 
A wide variety of biodegradable PHA intracellular polymers are naturally produced in a 
number of bacteria (Doi et al., 1992; Doi et al., 1995; Hrabak, 1992; Timm et al., 1994; Trainer 
and Charles, 2006). These polymers vary in their physical properties. Their natural role is 
typically to cope with the stress associated with fluctuating nutrient availability (Lee, 1996). 
Several of these polymers have been candidates for use as bioproducts, in many cases to replace 
fossil fuel-based materials. There are key challenges to the economic viability of production of 
these biopolymers, especially in competition with the established fossil fuel-based products. 
Ability to incorporate inexpensive feedstock would improve the economic feasibility of 
biopolymer production. In addition to naturally produced polymers, there have been efforts to 
produce new polymers with potentially interesting and useful properties.  
PLA is a biodegradable polymer that is currently produced chemically from biologically 
produced lactic acid derivatives using heavy metal catalysis (Taguchi et al., 2008), but is not 
known to be naturally produced by any microbe. It possesses several favourable properties such 
as high strength, biocompatibility, heat resistance, permeability and optical activity that make it a 
leading candidate for medical applications such as resorbable sutures, drug carriers, organ-
substituting implants and artificial blood vessels (Lunt, 1998; Södergård and Stolt, 2002). The 
co-polymer PLA-co-PHA has been obtained through ring-opening polymerization of L-lactide 
combined with PHA using stannous octoate as a catalyst (Haynes et al., 2007). In part to avoid 
64 
 
contamination with trace levels of heavy metal, research has focused on producing PLA and 
similar types of polymers through direct fermentation (Jung et al., 2010b; Selmer et al., 2002; 
Yang et al., 2010), despite the absence of natural production. It was determined that lactic acid 
(LA) and 3-hydroxyalkanoate (3HA) monomer, especially D-3-hydroxybutyrate, share a similar 
structure including both hydroxyl and carboxyl groups essential for the formation of an ester 
bond (Yang et al., 2010). 
Because the substrate specificity of PHA synthase enzymes varies, both natural isolates 
and engineered strains have been shown to successfully produce several different types of PHA 
copolymers containing both SCL and MCL monomers (Jung et al., 2010a). Based on these 
observations, efforts have been undertaken to develop a PHA synthase to promote the 
polymerization of LA-CoA to produce PLA homopolymer or P(LA-co-HB) copolymer. 
Following the reported discovery of a diverse range of PHA synthase substrates by an in vitro 
polymerization screening system (Tajima et al., 2004), a number of studies on producing this 
novel copolymer in vivo were undertaken. This resulted in successful in vivo production of PLA 
homopolymer and P(LA-co-HA) copolymer (Taguchi et al., 2008). In this study, however, the 
LA fraction that was incorporated into copolymer was quite low, at approximately 6 mol%.  
Since then, a number of engineered PHA synthases derived by site-directed mutagenesis as well 
as saturation mutagenesis have been screened for efficient incorporation of LA-CoA into P(LA-
co-HA) copolymer (Yang et al., 2010). The best performers were able to direct incorporation of 
LA monomer up to 50 mol%. The mole fraction of LA monomer was inversely proportional to 
the molecular weight and the crystallinity of P(3HB-co-LA), and directly proportional to the 
glass transition temperature (Tg) of the polymer. While Tg was apparently affected by the LA 
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fraction, the melting temperature (Tm) was just slightly affected by the LA monomer 
composition.  
To increase the LA monomer content in the copolymers, not only PHA synthase activity 
but also the flow of LA-CoA precursors needs to be considered. Efforts to construct a more 
efficient strain, with higher flux of LA-CoA precursors, were first carried out on an E. coli model 
system that was designed to produce either PLA or P(LA-co-HA). The first strategy aimed at 
engineering the propionate CoA transferase enzyme from Clostridium propionicum, which 
converts lactate into lactyl-CoA, by site-directed mutagenesis as well as saturation mutagenesis 
to improve the specificity of the enzyme (Yang et al., 2010). Subsequent strategies focused on 
modifying E. coli genes to either up-regulate the enzyme (D-lactate dehydrogenase ldhA, acetyl-
CoA synthetase acs) or abolish the enzyme (acetate kinase ackA, phosphoenolpyruvate 
carboxylase ppc, and acetaldehyde/alcohol dehydrogenase adhE) in order to draw LA monomer 
precursors toward the polymerizing step (Jung et al., 2010b).  
Given the goal of more efficient and less expensive production of LA-containing 
polymer, we decided to investigate the use of Sinorhizobium meliloti as a production platform. 
This soil bacterium, best known for its N2-fixing symbiosis with Medicago sativa (Alfalfa), is 
genetically amenable and metabolically versatile (Bélanger et al., 2009a; Gurich and González, 
2009). This organism has the advantage of having been used for many years in the agricultural 
inoculant industry, culturable to very high titres. It is a native P(3HB) producer that can 
accumulate P(3HB) up to 60-80% cell dry weight under growth-limiting conditions in the 
presence of excess carbon source (Trainer and Charles, 2006). The P(3HB) cycle in S. meliloti, 
which includes the well-studied P(3HB) synthesis and degradation pathways, resembles the 
P(3HB) cycles in other native P(3HB) producers. The first step in this cycle is the conversion of 
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acetyl-CoA into acetoacetyl-CoA catalyzed by phbA-encoded ketothiolase (EC 2.3.1.9). This is 
followed by acetoacetyl-CoA reductase (EC 1.1.1.36) encoded by phbB to convert acetoacetyl-
CoA into 3-hydroxylbutyryl-CoA. In the last step of the P(3HB) synthesis pathway, phbC-
encoded P(3HB) synthase (EC 2.3.1.B2) is responsible for polymerizing 3-hydroxylbutyryl-CoA 
into PHB. In S. meliloti, other enzymes taking part in this pathway are P(3HB) depolymerase 
(phaZ) (EC 3.1.1.75), 3-hydroxybutyrate dehydrogenase (bdhA) (EC 1.1.1.30), and acetoacetyl-
CoA synthetase (acsA2) (EC 6.2.1.16).  
In this study, we describe a system that enables engineered enzymes, which have been 
studied previously, to function in S. meliloti to produce P(3HB-co-LA). The engineered 
propionate CoA transferase enzyme is required to convert lactate into lactyl-CoA, which can 
then be polymerized with 3HB-CoA to make P(3HB-co-LA) by a modified PHA polymerase 
(Figure 3.1). The genes for these enzymes have been modified and codon-optimized for 
expression in S. meliloti. They were expressed from the native phaC promoter following 
integration into the S. meliloti chromosome. 
The advantages of this strategy are that the system is extremely stable and the genes are 
expressed using the native promoter. The genes are introduced into the genome at the phaC 
locus, hence they will be maintained permanently without the need of using antibiotics. We also 
took advantage of native promoter to express synthesized genes.  
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Figure 3.1 Metabolic engineering in S. meliloti for the production of novel polymers 
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3.2 Results and Discussion 
3.2.1  The rationale of employing codon-optimized engineered genes 
The amino acid sequences of two engineered genes pct532 and phaC1400, which encode 
engineered propionate CoA transferase from C. propionicum DSM 1682 and engineered PHA 
synthase I from Pseudomonas sp. MBEL 6-19, respectively, were used; pct532 had been 
randomly mutated using error-prone PCR (A243T, one silent nucleotide mutation of A1200G), 
while gene phaC1400 was engineered by saturation and site-directed mutagenesis (E130D, 
S325T, S477R, Q481M). Combining these evolved genes has been proved to improve the lactate 
fraction in P(3HB-co-LA) copolymer production (Jung et al., 2010b). These genes were codon-
optimized for S. meliloti using the codon adaptation tool JCat (Grote et al., 2005). The optimized 
sequences, with a His tag of six histidine residues at the end of each gene (before the stop 
codon), and a ribosome binding site (RBS) at the beginning of each gene, were then synthesized 
on a single fragment, with phaC1400 immediately following pct532.  The DNA sequence of the 
synthesized fragment has been included in Supplementary 1.  
Comparing the engineered genes before and after codon optimization revealed that the 
overall GC content increased for both genes (for the pct gene, the GC content increased from 
40.38% to 53.65%; for the phaC gene, the GC content increased from 58.86% to 62.14%), while 
the codon diversity decreased across both genes (for the pct gene, the number of codons 
decreased from 52 to 37; for the phaC gene, the number of codons decreased from 56 to 39). The 
pct gene originated from Clostridium propionicum which has fairly low GC content compared to 
S. meliloti. Therefore, there was a significant increase in GC content for this gene. After the 
codons were optimized, there were four scenarios observed: the appearance of new codons, the 
disappearance of existing codons, increase of the proportion of certain codons, and the 
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maintenance of the same percentage of others. Meanwhile, the phaC gene originated from P. 
putida had GC content that is quite similar to that of S. meliloti. This explains why the GC 
content of this gene remained nearly the same. There were also four changes in the replacement 
of codons in phaC gene, but not all the same. The first scenario which is the appearance of new 
codons was not found in this optimized gene. Instead, the remarkable decrease of only one codon 
(CAA encoding glutamine) was seen. However, these genes were only partially optimized since 
we also desire to examine these genes in a broad range of different host backgrounds which have 
different codon usage and prefer lower GC content. Had we not chosen “the partial optimization” 
option, the GC content would have increased more (64.7% and 65.11% for the pct and phaC 
genes, respectively); and the number of codons would have severely dropped to 20 codons for 
both of the genes. These fully optimized sequences could be the ideal sequences for expression 
in S. meliloti, but this also would restrict the genes from being expressed in other host strains. 
Hence, there is a trade-off between gene expression optimization and host strain flexibility. 
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Figure 3.2 Comparison of codon usage in S. meliloti, codon usage of engineered pct gene before 
and after optimization 
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Figure 3.3 Comparison of codon usage in S. meliloti, codon usage of engineered phaC gene 
before and after optimization 
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3.2.2 Construction of S. meliloti strain harbouring synthetic codon-optimized pct532 and 
phaC1400 genes integrated into the chromosome 
We constructed a suicide plasmid for substitution of the S. meliloti phaC gene, which 
encodes the native PHA synthase enzyme, with the codon optimized pct532 and phaC140 genes, 
under the control of the native phaC promoter. To achieve this, roughly 300 bp-long fragments 
were taken from immediately upstream of the S. meliloti phaC start codon and immediately 
downstream of the stop codon; the fragments were designed to flank the optimized pct532 and 
phaC140 genes, and  this designed construct was chemically synthesized (Biobasic). The 
construct was then cloned into the XbaI site of the suicide vector pK19mobsacB to create 
pK19pctPhaC as shown in Figure 3.4. This plasmid was introduced into S. meliloti Rm11144, 
which harbours a Tn5-233 insertion in phaC (Trainer et al., 2010), by triparental conjugation 
from E. coli DH5α, with selection for Nmr. Double crossover mutants were recovered following 
selection on TY containing 5% sucrose, followed by screening for loss of Tn5-233-encoded 
Gm/Sp
r
.  This process is illustrated in Figure 3.5 .Two colonies, which were neither sucrose-
sensitive nor Gm-sensitive, were randomly picked to be tested by colony PCR. Colony PCR 
analysis with two sets of primers (VPhbC_F and VPhbC_R1; VPhbC_F1 and VPhbC_R) 
confirmed precise replacement of the phaC ORF by the synthesized genes. The resulting strain 
was designated SmUW254. The results were shown in Figure 3.6. Primers VPhbC_F and 
VPhbC_R1 were designed to be complementary to a region outside homologous region 1 (HR1) 
and within the pct gene, respectively. Primers VPhbC_F1 and VPhbC_R were designed to be 
complementary within the phaC gene and outside homologous region 2 (HR2). Lane 1 and lane 
2 showed expected bands (1194 bp and 1116bp, respectively) using above primer sets to confirm 
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the integrant strain SmUW254. Lane 3 and lane 4 did not show any bands using the same primer 
sets in the parental strain Rm11144. 
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Figure 3.4 Plasmid construction of suicide vector pK19pctphaC. The synthesized fragment, 
including two synthesized genes (pct and phaC) flanked by upstream and downstream phbC 
fragments, was cloned into pK19mobsacB to create suicide vector pK19pctphaC. 
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Figure 3.5 Diagram of gene integration into S. meliloti background using a double-crossover 
technique. 
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Figure 3.6 Confirmation of a successfully gene-integrated strain using colony PCR 
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3.2.3 Phenotypic analysis of strain constructs 
Initial confirmation of polymer production in the engineered strains was performed on 
Nile Red-containing YM agar plates using the Fluorescence Theatre (Heil et al., 2011). The 
strain SmUW254 were streaked out alongside Rm1021 and Rm11144 as phaC-positive and 
phaC-negative controls, respectively (Figure 4). SmUW254 exhibited fluorescence similar to the 
wild-type strain Rm1021, while the phaC mutant strain Rm11144, which cannot produce 
P(3HB), was deficient in fluorescence. The engineered strains also restored the 
exopolysaccharide-linked mucoid colony morphology on high-carbon growth media that is 
correlated with PHA accumulation (Aneja et al., 2004; Schallmey et al., 2011).  
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Figure 3.7 Phenotypic complementation of chromosome-engineered strains. A and B 
demonstrate phenotypic difference between chromosome-engineered S. meliloti strains and other 
S. meliloti strains: parental strain Rm1021 (phbC+), mutant strain Rm11144 (phbC) and 
engineered strain SmUW254. A) normal image, B) fluorescent image  
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3.2.4 Polymer production in chromosomal engineering system 
The major objective of this study was to engineer S. meliloti to produce novel polymers. 
Integration of the engineered genes onto the chromosome should improve production strain 
stability. The chromosomal integrant strain SmUW254 can produce polymer content of 15% 
approximately, which is slightly lower than the wild-type strain (20%). However, LA can only 
be detected in the engineered strain SmUW254 and constituted 30% mol (Figure 3.8). An 
important difference between using S. meliloti and E. coli is that the production of co-polymer in 
the engineered S. meliloti strain did not require the provision of exogenous 3HB substrate, since 
D-3-hydroxybutyrl-CoA is naturally formed through the action of the native phaAB gene 
products.  
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Figure 3.8 Polymer production in engineered strains. Polymer content and LA fraction analysis 
in parental strain Rm1021 and engineered strain SmUW254. Only SmUW254 can accumulate 
roughly 30 mol% LA. The experiment was done in duplicate. Error bars represent the range of 
the mean. 
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To further investigate as well as confirm the structure of this copolymer, we carried out 
the purification of the copolymer. The purified polymer was analyzed using GC/MS and NMR. 
The NMR 
1
H and 
13
C spectrum of the purified polymer were identical to those of PLA 
homopolymer from published studies (Jung et al., 2010b; Taguchi et al., 2008; Yang et al., 
2010), except for CH2 peak which accounted for the presence of 3HB monomer (Figure 3.9). To 
confirm the presence of LA monomer, we also carried out the analysis of structure using 
GC/MS. The result also matched the retention time of the LA standard and the mass spectrum in 
the library (Figure 3.10).  
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Figure 3.9 NMR analysis of purified polymer. A. The 
13
C NMR spectrum of purified polymer. B. 
The 
1
H NMR spectrum of purified polymer. C. The chemical structure of purified polymer. D. 
The COSY NMR spectrum of purified polymer. 
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Figure 3.10 GC/MS analysis of purified polymer. The figure shows the LA monomer fraction 
peak. The arrow indicates the mass spectrum of this fraction (top) which matched with the LA 
structure  in the library (bottom).   
84 
 
3.3 Conclusions 
Here we have presented the strategy of chromosome engineering to engineer S. meliloti to 
make it a robust platform for polymer production. It was shown that this system was able to 
produce P(3HB-co-LA) copolymer. Our work has shown for the first time that S. meliloti has the 
ability to produce this type of polymer through the application of metabolic engineering tools. 
We intend to follow these results with further in-depth studies on biopolymer production in 
general, and novel polymer production in S. meliloti specifically.  
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Chapter 4 Plasmid-based engineering in 
Sinorhizobium meliloti  
4.1 Introduction 
In this chapter, another strategy has been used to engineer S. meliloti as a host for the 
production of novel polymers. Engineered genes which have been described in detail in Chapter 
3 were expressed from a plasmid rather than from the chromosome. There have been a number 
of studies which employed this strategy to examine heterologous gene expression in bacteria, 
commonly E. coli, using constitutive or inducible promoters (Borrero-de Acuña et al., 2014; 
Fukui et al., 1998; Fukui and Doi, 1997; Klinke et al., 1999; Taguchi et al., 2008). For the 
production of P(LA-co-3HB) copolymer or PLA homopolymer, previous studies employed E. 
coli as a host and expressed engineered heterologous genes carried by a plasmid (Jung et al., 
2010b; Taguchi et al., 2008; Yang et al., 2010).  
The expression vector pTH1227 that was used is a pFUS derivative vector carrying an 
RK2 origin, inducible pTac- lacI
q
 promoter and gusA gene as a reporter (Cheng et al., 2007; 
D’Haeze et al., 2004; Marsh et al., 1984; Reeve et al., 1999; Spaink et al., 1987). This vector is a 
broad-host range expression vector that has been used to study the role of the minCDE genes in 
both S. meliloti and E. coli (Cheng et al., 2007). The related vector pMP220 has been used in 
Azorhizobium caulinodans (D’Haeze et al., 2004). It was also used for insertional mutagenesis, 
transcriptional signal localization and gene regulation studies in root nodule bacteria such as S. 
meliloti, Bradyrhizobium sp. and R. leguminosarum bv. Viciae (Reeve et al., 1999). The gusA 
gene from E. coli encoding β-glucuronidase was used in different host backgrounds as a reporter 
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gene (Cheng et al., 2007; Myronovskyi et al., 2011; Reeve et al., 1999; Russell and 
Klaenhammer, 2001; Saborido Basconcillo et al., 2009). The β-glucuronidase (Gus) product can 
be easily detected by observation of colour change on media containing chromogenic substrates 
such as X-GlcA (5-bromo-4-chloro-3-indolyl β-D-glucuronide, cyclohexyl-ammonium salt), 
other 3-indoxyl derivatives, and naphthol-β-D-glucuronide. In addition, it also can be 
quantitatively measured by spectrophotometry (p-nitrophenyl β-D-glucuronide and 
phenolphthalein-β-D-glucuronide), fluorimetry (4-methylumbelliferyl-β-D-glucuronide and 5-
dodecanoyl- aminofluorescein-di-β-D-glucuronide) or chemiluminescence (1,2-dioxetane-β-D-
glucuronide). Gus has been widely used to study gene expression and other applications because 
the enzyme is highly stable, resistant and easily detected.  
The pTac-lacI
q
 transcriptional regulatory system is well known as an inducible system 
first developed in E. coli (Amann and Ptaslme, 1983; De Boer et al., 1983; Letouvet-Pawlak et 
al., 1990). The tac promoter is a hybrid derived from the lac and trp promoters. It contains the 
Pribnow box or -10 region of the lacUV5 promoter with consensus sequence TATAAT and the -
35 region of the trp promoter with consensus sequence TTGACA at the position -20 with respect 
to the transcriptional start site.  It is a well known strong promoter. The lacI
q
 allele of lacI has a 
mutated promoter sequence that results in enhanced expression up to 10-fold (Calos, 1978; Stark, 
1987).  
The advantages of expressing the gene from a plasmid under the control of a regulatable 
promoter include flexibility, tunable expression and ability to easily transfer the genes to a broad 
range of potential host strains. 
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4.2 Results and discussion 
4.2.1 Construction of plasmid expressing synthetic codon optimized pct532 and phaC1400 genes  
The broad host range vector pTH1227, containing the inducible tac promoter and lacI
q
 
along with a downstream gusA reporter gene, was digested with XhoI and PstI, then ligated with 
the XhoI / PstI -digested synthesized DNA as shown in Fig. 4.1. This resulted in the plasmid 
construct pTAM. The pTAM plasmid and the empty vector control pTH1227 were separately 
introduced into E. coli DH5α and a selection of S. meliloti phbC mutant (SmUW499) strains. 
Transcription of the introduced genes was confirmed by assay of gusA-encoded β-glucuronidase 
activity. 
 
  
88 
 
 
Figure 4.1 Construction of expression plasmid pTAM. Two synthesized, codon optimized genes 
(pct and phaC) were inserted as a XhoI-PstI fragment into pTH1227 to create pTAM. 
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4.2.2 Phenotypic analysis of strain constructs 
 Initial confirmation of polymer production in the constructed strain SmUW256 was 
carried out in the same way as previously described for the chromosome engineered strain 
SmUW254. The strain was streaked out alongside the parental strain and mutant strain as phaC-
positive and phaC-negative controls, respectively. Strain SmUW256, which is the phaC mutant 
containing pTAM, exhibited fluorescence similar to the control strain SmUW257, which 
contains pTH1227 in a non-mutant phaC background. The phaC mutant strain SmUW255, 
containing pTH1227, which cannot produce P(3HB), was deficient in fluorescence, as expected. 
Interestingly, in the absence of inducer IPTG, we found that SmUW256 exhibited much more 
fluorescence than with IPTG. This suggested that the gene expression from the plasmid construct 
was sufficient without IPTG induction to allow complementation. 
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Figure 4.2 Phenotypic complementation of PHA synthesis associated phenotype in S. meliloti 
strains. A and B demonstrate phenotypic difference between between plasmid-based engineered 
S. meliloti strains and other S. meliloti strains SmUW255 (phaC

), SmUW256 (#1, #3), 
SmUW257 (phaC
+
). A) Inducing condition (IPTG), B) Non-inducing condition (No IPTG).  
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4.2.3 Confirmation of expression of the plasmid-encoded engineered enzymes  
To confirm the expression of the engineered enzymes from the pTAM plasmid in the 
SmUW256 strain, we performed SDS-PAGE and His-tag staining analysis. Each of the two 
enzymes had a C-terminal 6-His tag. Because the sizes of these two enzymes are very similar 
(~60 kDa), only one positive band was observed on the gel (Fig. 4.3). We also tested these 
samples in the absence of IPTG, and surprisingly, a very light band was seen on the gel, 
suggesting a moderate level of expression under non-inducing conditions. In addition, the 
function of the engineered enzymes was confirmed by the production of different types of 
polymers, which were detected by gas chromatography analysis, presented below.  
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Figure 4.3 Gel image of SDS-PAGE analysis. His-tag staining of positive His-tagged control 
which is used to test the working conditionof reagents (Lane 1), negative His-tagged control 
SmUW255 and SmUW257 (Lanes 2 and 3, respectively), and two samples of the plasmid-based 
construct (Lanes 4 and 5). 
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4.2.4 Polymer production in plasmid-based system 
a. P(3HB) and PLA production 
We took advantage of the inducible expression plasmid pTH1227, which has been well-studied 
in S. meliloti (Cheng et al., 2007). In this system, engineered genes were expressed in a phbC 
mutant background under the control of inducible promoter Ptac by means of the plasmid-encoded 
lacI
q
. Surprisingly, in the absence of IPTG supplementation in YM media, levels of P(3HB) 
produced were similar to the wild-type levels, but in the presence of 0.4 mM IPTG, P(3HB) was 
only accumulated to about half the wild-type levels. In both conditions, LA was not detected 
(Figure 4.4). To investigate whether this was due to issues related to competition between 
P(3HB) and PLA precursors, we blocked the P(3HB) synthesis pathway by using a phaAB phaC 
mutant background. Feeding the strain with lactic acid (10 g l
-1
) as a mannitol-substituting 
substrate in YM media resulted in PLA homopolymer production of 4% DCW (Table 4.1), 
demonstrating that in the absence of competing P(3HB) precursors, the PLA precursors could be 
incorporated into polymer. Also, we have tested the polymer production in other mutant S. 
meliloti backgrounds (Table 4.2). However, only P(3HB) was found to be produced in these 
mutants. 
b. Investigation of IPTG concentration and induction time 
In light of the unexpected observation that greater amounts of polymer were produced in the 
absence of IPTG induction than in the presence of IPTG, we decided to further investigate the 
P(3HB) production under different induction conditions. We also measured GusA expression 
from the downstream gusA gene as a proxy for transcription across the engineered genes. A 
range of IPTG concentrations from 0 to 1 mM was used to induce gene expression (Figure 4.5). 
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At an IPTG concentration of 0.05 mM, GusA activity in the SmUW256 strain increased 
markedly compared to that in the absence of IPTG. However, further addition of IPTG did not 
substantially increase GusA activity in recombinant strain SmUW256. Meanwhile, the control 
strain SmUW255 which harbours the empty plasmid pTH1227, showed gusA expression in 
rough proportion to IPTG concentration. Contrary to expectations, increased gene expression did 
not result in more P(3HB) being produced (Fig. 4.7); however, both DCW and yield decreased 
relative to increased IPTG concentration. Interestingly, the basal level of expression provided the 
strain with the best conditions to grow and produce P(3HB) based on the highest DCW, yield 
and P(3HB) percentage. We also tested the ability for P(3HB) production at a range of lower 
IPTG concentrations (Fig. 4.8). There was no significant difference in P(3HB) accumulation 
under these conditions, compared to the amount accumulated at the basal level of expression. 
Next, the effect of induction timing was investigated to see if the cells behaved 
differently when 0.4 mM IPTG was added later in the culturing. We observed that the later the 
IPTG was added, the more GusA activity was decreased (Fig. 4.6). Therefore, if we only 
consider reporter gene expression level, induction at the beginning of cultivation is the most 
optimal; however, whether reporter gene expression is directly proportional to P(3HB) 
production is a separate issue that we sought to resolve. Once again, the results show that this 
relationship is inversely proportional (Fig. 4.9). Both DCW and yield significantly decreased 
when the induction occurred at the beginning of cultivation, resulting in the lowest P(3HB) 
percentage. Induction at Day 1 or 2 of cultivation did not make a significant difference compared 
to no induction, suggesting that the basal level is still ideal for P(3HB) production.  
The question of the optimal level of synthase protein level for polymer production is still 
unanswered. The rationale is generally that with more protein being expressed, more target 
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products can be formed. This is why some studies focus on maximizing the products by 
overexpressing genes in the pathway. However, these two factors are not always directly 
proportional to each other. High protein levels do not necessarily translate into greater product 
amounts (Prather, 2010). For instance, it was reported that E. coli XL1-Blue harbouring the low-
copy-number plasmid pJRDTrcphaCABRe produced P(3HB) more efficiently than the strain 
harbouring the high copy number pTrcphaCABRe (Kahar et al., 2005). However, in this study, 
the induction time and IPTG concentration were not taken into consideration. In all cases, 0.5 
mM IPTG was added into the media at 24 h of cultivation; therefore, it may be that variable 
results can be obtained using the same low copy number plasmid under different conditions. 
There is still not a good understanding of the relationship between PHA synthase gene 
expression and levels of polymer accumulated.  
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Figure 4.4 Polymer content of SmUW255 (phaC

), SmUW257 (phaC
+
) and SmUW256 
(engineered phaC). Dark grey bars represent inducing condition (0.4 mM IPTG was added to 
cultures); light grey bars represent non-inducing condition (no IPTG). The experiment was done 
in duplicate. Error bars represent the range of the mean. 
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Figure 4.5 Measurement of gusA activity of strain SmUW256 induced at different concentrations 
of IPTG. The experiment was done in duplicate. Error bars represent the range of the mean. 
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Figure 4.6 Measurement of gusA activity of strain SmUW256 induced at 0.4 mM IPTG at 
different points in time for 3 day incubation. The experiment was done in duplicate. Error bars 
represent the range of the mean.  
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Figure 4.7 P(3HB) content produced by strain SmUW256 induced at different concentrations of 
IPTG. The experiment was done in duplicate. Error bars represent the range of the mean.
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Figure 4.8 P(3HB) content produced by strain SmUW256 induced at a lower range of IPTG 
concentration.  The experiment was done in duplicate. Error bars represent the range of the 
mean. 
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Figure 4.9 P(3HB) content produced by strain SmUW256 induced 0.4 mM IPTG at different 
points in time for 3 day incubation.  The experiment was done in duplicate. Error bars represent 
the range of the mean. 
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Table 4.1 PLA production in phaAB phaC mutant (SmUW501 background) harbouring pTAM 
Strains were cultured in YEM supplemented with lactic acid at different concentrations. 
SmUW558: ΔphaAB ΔphaC (pTH1227), SmUW559: ΔphaAB ΔphaC (pTAM). - : Not available. 
ND:  Not detectable 
 
 
  
 
Lactic acid concentration 
  10 g/l  20 g/l 30g/l 10 g/l  20 g/l 30g/l 
Strain PLA content (%) DCW (g/l) 
SmUW558 (control) ND - - 
0.43 ± 
0.03 - - 
SmUW559 
3.2 ± 
1.8 
0.18 ± 
0.13 ND 
0.35 ± 
0.05 
0.16 ± 
0.05 ND 
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Table 4.2 Polymer production in different mutant S. meliloti backgrounds 
Strains Carbon source 
  Mannitol (10 g/l) Lactic acid (10 g/l) 
 
DCW (g/l) P(3HB) (%) DCW (g/l) PLA (%) 
SmUW550 0.39 ±0.009 nd 0.48 ±0.01 nd 
SmUW551 0.6 ± 0.069 nd 0.52 ± 0.06 nd 
SmUW552 0.47 ±0.032 nd 0.42 ±0.007 nd 
SmUW553 0.45 ± 0.02 nd 0.62 ± 0.058 nd 
SmUW554 0.34 ±0.04 nd - - 
SmUW555 
0.48 ± 
0.005 7.18 ± 1.03 
- 
- 
SmUW556 0.66 ± 0.05 14.9 ± 1 - - 
SmUW557 0.73 ± 0.04 13.9 ± 0.45 - - 
Strains were cultured in YEM supplemented with either mannitol or lactic acid. SmUW550: 
ΔphaAB (pTH1227), SmUW551: ΔphaAB (pTAM), SmUW552: ΔphaAB ΔphaZ (pTH1227), 
SmUW553: ΔphaAB ΔphaZ (pTAM), SmUW554: phaC phaZ (pTH1227), SmUW555: 
phaC phaZ (pTAM), SmUW556: phaZ (pTH1227), SmUW557: phaZ (pTAM). For full 
description of strains, please refer to Table 2.1.  
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4.3 Conclusions 
In this chapter, we have demonstrated that the synthesized pct - phaC was able to complement 
the phaC mutant strain. However, the flow of LA precursor is apparently insufficient in this 
system, resulting in the strains-accumulating only P(3HB). It was also found that the enzyme 
activities did not proportionally correlate with polymer accumulation, and the strain produced 
P(3HB) the most efficiently at the background level. The strain that had the P(3HB) production 
pathway completely removed was able to produce PLA homopolymer up to 4% when growing in 
YEM supplemented with lactic acid.  
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Chapter 5 Metabolic Engineering in 
Pseudomonas putida background 
5.1 Introduction 
 Pseudomonas putida is classified within the Gammaproteobacteria, and are Gram-
negative, chemoorganotrophic aerobic rods with polar flagella. P. putida can naturally produce 
MCL PHA either from non-related carbon sources such as glucose, or related carbon sources 
such as fatty acids. It can accumulate PHA up to 75% DCW under carbon-limiting conditions 
(Le Meur et al., 2012). Also, the complete genome sequence of P. putida KT2440 is available, 
and the strain is genetically amenable, which is beneficial for manipulating metabolic pathways 
(Timmis, 2002). It grows fast and can be found in many terrestrial and aquatic ecosystems. For 
these reasons, this strain has become a very promising candidate to be a robust host for novel 
polymer production.  
 MCL PHAs are composed of monomers that contain 6-14 carbons. They are produced as 
intracellular storage compounds in many Pseudomonas strains under unbalanced growth 
conditions (Le Meur et al., 2012; Sudesh et al., 2000). The 3-hydroxyacyl-CoA precursors are 
derived from the intermediates of the fatty acid β-oxidation pathway during growth on fatty acids 
under nitrogen limitation. In addition, these precursors also can often be obtained through fatty 
acid de novo biosynthesis from unrelated carbon sources such as carbohydrates. Depending on 
the composition as well as the length of the alkyl side chain, material properties vary to a great 
extent from hard crystalline plastics to elastic rubbers. MCL PHAs exhibit the properties of low-
melting points, high elasticity and thermoelastomers (Jiang et al., 2006).  
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The objective of this study was to take advantage of the existing copolymer plasmid 
expression system that was demonstrated in S. meliloti, and investigate its use in P. putida, a 
well-known MCL PHA producer. A primary goal was to combine the plasmid-based system and 
the native P. putida system to produce a novel type of polymer. The engineered PhaC synthase 
was shown, in S. meliloti, to be able to accept SCL PHA, specifically 3HB, as well as LA 
monomers. This enzyme is derived from the Type II PhaC synthase from Pseudomonas sp. 
MBEL 6-19 strain, and consistent with this origin it could also accept MCL PHA monomers. By 
replacing the P. putida PhaC synthase with this engineered enzyme, a novel polymer composed 
of 3HB, LA and different types of MCL PHA might be produced. It was demonstrated that 
improved properties have been achieved by blending different types of polymers to meet a wider 
range of practical applications (Koning, 1995; Sudesh et al., 2000). In the search for such a novel 
polymer, this strategy could result in the generation of new types of polymer which possesses 
valuable and useful properties. 
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5.2 Results 
5.2.1 Introduction engineered synthesized genes into P. putida and expression under control 
of an inducible promoter 
All of the strains used in this chapter are listed in Table 2.1. The pTAM vector that was 
constructed and expressed in S. meliloti as described in Chapter 4 was introduced into both the 
phaC1-phaZ-phaC2 mutant and the wild-type P. putida KT2440 strain by triparental 
conjugation; the new strains were named as PPUW19 and PPUW21, respectively. The empty 
plasmid pTH1227 was also introduced into the mutant and wild-type strains, and the resulting 
strains were named as PPUW18 and PPUW20 . Since we observed an adverse effect on polymer 
production in S. meliloti under inducing conditions, these genes were expressed under pTac 
promoter in the absence of IPTG in P. putida.  
5.2.2 Phenotypic analysis of strain constructs 
The phenotype of P. putida harbouring the expression plasmid was taken into 
consideration when the strains were grown on LB supplemented with sodium octanoate. 
Interestingly, we found that the strains carrying the pTAM plasmid showed a distinguishable 
phenotype from the strains only carrying the empty plasmid pTH1227 (Figure 5.1). Both the wild 
type and mutant strains containing the pTAM plasmid showed a milky white colony phenotype, 
while the strains that carried only the empty plasmid pTH1227 had a yellowish colony color. The 
milky white colour is likely due to polymer accumulation enabled by pTAM. P. putida KT2440 
is known to only accumulate PHA under unbalanced growth conditions, but to our knowledge, 
there is no study investigating the ability to accumulate polymer when cultured in complex 
media. It appears that the function of the native PhaC synthase, and not other enzymes in the P. 
putida PHA biosynthesis pathway, is affected when the strain is cultured in nutrient media with 
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excess carbon source because the engineered PhaC synthase was able to direct the accumulation 
of PHA on complex media.  
 We also investigated colony fluorescence on Nile Red containing plates with different 
growth media (Figure 5.2). On LB plates without the addition of any extra carbon source, no 
fluorescence was observed for any of strains. Only strains harbouring pTAM plasmid showed a 
strong fluorescence when grown on LB plates with an excess carbon source (eg. sodium 
carbonate). Meanwhile, there were no evident phenotypic differences when the strains grew on 
either only LB or LB with lactic acid.  
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Figure 5.1 Phenotype of strains on LB supplemented with sodium octanoate. A milky white 
phenotype was observed for PPUW19 (phaC mutant harbouring pTAM) and PPUW 21 (wild-
type strain harbouring pTAM). Yellowish phenotype was observed for PPUW18 (phaC mutant 
harbouring pTH1227) and PPUW20 (wild-type strain harbouring pTH1227) 
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    LB + NR      LB + Sodium octanoate + NR 
 
 
 
 
 
LB + Lactic acid + NR 
Figure 5.2 Fluorescence observation of different P. putida strain backgrounds. PPUW18 (phaC 
mutant harbouring pTH1227), PPUW19 (phaC mutant harbouring pTAM), PPUW20 (wild-type 
KT2440 harbouring pTH1227), PPUW21 (wild-type KT2440 harbouring pTAM). 
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5.2.3 GC analysis of polymers produced in P. putida strains growing in minimal media 
supplemented with either sodium octanoate and lactic acid as a substrate 
 Strains were cultured in defined media 0.5E2, whose recipe can be found in the 
Appendix, supplemented with either sodium octanoate or lactic acid. The negative control strain 
PPUW18, which is the P. putida phaC mutant strain carrying the empty plasmid pTH1227 was 
not able to produce polymers. Overall, the media containing sodium carbonate as sole carbon 
source supported both the growth and the capability of polymer production much better than 
media with using lactic acid as sole carbon source (Figure 5.3). The mutant with pTAM plasmid 
showed the highest DCW and polymer content up to 1.28 g/l and 42%, respectively, using 
sodium octanoate. Remarkably, the strains carrying the pTAM plasmid were able to incorporate 
LA monomers to generate a novel polymer composed of LA, 3HB, 3HHx and 3HO. A 
copolymer of this type has, to our knowledge, never been reported. The production of P(LA-co-
3HB-co-3HHX) was previously demonstrated in E. coli via a reverse reaction of the β-oxidation 
pathway (Shozui et al., 2010a). In that study, the E. coli strain was equipped with LA- 
polymerizing enzyme (LPE) encoding a mutant phaC1 gene from Pseudomonas sp. 61-3, 
propionyl-CoA transferase (PCT) and (R)-specific enoyl-CoA hydratase (PhaJ4). However, it is 
difficult to understand how, in that particular study, 100% P(3HB) was produced during growth 
in LB supplemented with glucose since there is no link between the fatty acid synthesis pathway 
with PHA precursor formation in E. coli. In previous studies, E. coli was able to produce a small 
amount of MCL PHA from non-related carbon source only when provided with a PHA 
polymerase and a modified thioesterase I (Klinke et al., 1999).  In addition, the polymer content 
of P(LA-co-3HB-co-3HHX) produced in E.coli was extremely low (<5% DCW). 
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We found that lactic acid supplied more LA precursors than sodium octanoate; therefore  
both the wild-type strain and the mutant strain carrying pTAM accumulated LA of 2.8 and 1.9% 
mol. Lactic acid is a direct substrate of the modified propionate-CoA transferase, whose function 
is to add the CoA moiety onto the substrate. Even though lactic acid did not support the cell 
growth as well as sodium octanoate, it supplied more LA precursor toward novel polymer 
production. This implies that the P. putida system did not produce lactyl-CoA efficiently from 
the sodium octanoate substrate.  
5.2.4 GC analysis of polymers produced in P. putida strains growing in LB supplemented 
with either sodium octanoate or lactic acid as a substrate 
 Since we observed different phenotypic characteristics on LB agar supplemented with 
sodium octanoate as described above, we wanted to examine, by GC analysis, what specific 
types of polymers were produced. As we expected, the polymer production reflects what we 
observed on the agar plates (Figure 5.4). All the strains produced a relatively low amount of 
polymers when grown in LB supplemented with lactic acid as a sole carbon source. This is the 
reason that we observed very low fluorescence on the plate. The phaC mutant strain harbouring 
pTAM produced the most polymer content (3.3% DCW) and LA monomer fraction (4% mol) in 
lactic acid supplemented LB. This LA monomer fraction was also found to be the highest 
obtained among all culture conditions. The wild-type strain harbouring the empty plasmid hardly 
produced any polymer in nutrient media regardless of what carbon source was used. However, 
surprisingly, the introduction of the pTAM plasmid restored polymer production up to 25.3% 
DCW in LB supplemented with sodium octanoate. This could be explained by inhibition of the 
native PhaC in nutrient media, rendering it unable to polymerize precursors. The heterologous 
enzyme, nevertheless, was perhaps able to overcome such inhibition. This also implies that the 
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flow of precursor molecules was always continuous in both defined and nutrient media as long as 
there was abundant carbon source.  
It has been suggested that the engineered PhaC enzyme has a broader substrate range than 
the native P. putida PhaC. The engineered PhaC synthase was originally Type II PhaC1 synthase 
that accepts and polymerizes MCL-3HA (C6-C14) monomers (Yang et al., 2010). This enzyme 
was engineered to broaden the substrate range towards SCL-3HAs (specifically, 3HB) and LA. 
Nonetheless, whether it still retains its ability to accept MCL-3HA has not previously been 
demonstrated. The fraction of LA and 3HB monomers in the copolymer increased substantially 
with the presence of engineered PhaC synthase, irrespective of media. This fraction was 
increased in mutant PhaC strain to a greater degree than the strain that still contained the wild 
type phaC genes, probably because either there is precursor competition between the polymerase 
enzymes in the wild-type strain or the overall polymerase enzyme activity towards MCL PHAs is 
higher in the wild-type resulting in the increase of MCL fraction over LA and 3HB fraction. In 
conclusion, we demonstrated that enhanced activity has been achieved, in which not only SCL-
3HA and LA monomers but also MCL-3HA monomers have been accepted by this enzyme. 
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Figure 5.3 Polymer production in different P. putida backgrounds growing in 0.5E2 media supplemented with either lactic acid or 
sodium octanoate. Left axis represents the polymer content (yellow squares)  and monomer composition (bars). Right axis represents 
polymer concentration (g/l) and DCW (g/l). 
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Figure 5.4 Polymer production in different P. putida backgrounds growing in LB media supplemented with either lactic acid or 
sodium octanoate. Left axis represents the polymer content (yellow squares)  and monomer composition (bars). Right axis represents 
polymer concentration (g/l) and DCW (g/l). 
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5.3 Conclusions 
 Here we have demonstrated that the plasmid expression system worked well in a different 
platform other than S. meliloti. A new type of polymer P(3HB-co-LA-co-3HHx-co-3HO) has 
been produced by expressing modified genes in P. putida. The phaC mutant strain produced this 
type of polymer the most efficiently with the polymer content of 36.4% DCW when cultured in 
0.5E2 with the addition of sodium octanoate, while the greatest LA fraction (4 mol%) was 
achieved in the same strain cultured in LB with the addition of lactic acid. Polymer production, 
specifically native PhaC polymerase activity, is dependent on the type of media used. The 
nutrient media LB supplemented with sodium octanoate appeared to repress the enzyme activity 
of native PhaC, but not engineered PhaC. The LA and 3HB monomer composition was higher 
when engineered PhaC was expressed alone than when engineered PhaC was co-expressed with 
native PhaC.  
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Chapter 6 Promoter Engineering 
6.1 Introduction 
 Promoter engineering has been considered as one of the critical strategies in the 
metabolic engineering field. A number of studies have been carried out to predict and 
characterize the promoter strength using in silico and/or wet-lab experiments (Davis et al., 2011; 
MacLellan et al., 2006; Murphy et al., 2007; Rhodius and Mutalik, 2010). Strong promoters are 
normally desired to maximize the end products, which could be proteins, amino acids, polymers 
or biofuel, and reduce toxicity during the growth phase. However, promoter strength and optimal 
yield of end products are not always correlated proportionally; therefore, promoters that are fine-
tunable and tightly controlled are more beneficial and versatile. The inducible promoter Ptac has 
been employed and presented in previous chapters. Here we present another approach to obtain a 
broad range of constitutive promoter strengths with no inducer required  
6.1.1 The structure of polymerase and bacterial transcription 
 The process of transcription in bacteria is comprised of three steps: initiation, binding and 
elongation. The structure of bacterial RNA polymerase which is a multi-subunit complex is 
normally composed of core components (ββ'αω) and one of several σ subunit types. The σ 
subunit is responsible for initiating transcription via searching and binding to two hexameric 
DNA sequences at the -10 and -35 positions. These positions contain conserved sequences 
known as motifs that are found in numerous promoters; for example, consensus sequence in E. 
coli promoters are –35 “TTGACA” motif and a –10 “TATAAT” motif (Blazeck and Alper, 
2013). These motifs are separated by a non-conserved sequence of roughly 17 base pairs. 
Besides promoter elements located at -10 and -35 position, there is the participation of the third 
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element (UP element) which consists of AT rich sequence residing upstream of -35 region. This 
third promoter element interacts with the C-terminal domain of the α subunit and can act as 
promoter facilitator to enhance the promoter activity (Meng et al., 2001). Upon binding, the 
double-stranded DNA sequence from approximate positions -10 to +2 is melted and separated 
into single strands to form the open complex and initiate the transcription. Before the polymerase 
is able to successfully proceed to elongation, it sometimes goes through a repetitive process, 
known as abortive transcription, in which the polymerase produces a short RNA transcript (<10 
nt) and returns to the start site until it is able to escape from the σ subunit and move forward. To 
learn more about the relationship between σ subunit structure and abortive transcription, σ70 was 
mutated by changing a single amino acid in the conserved protein region 3 (Hernandez et al., 
1996). It was found that a pattern of abortive RNAs was qualitatively different between the 
mutants and the wild-type σ. A similar level of short abortive RNAs was detected for mutants 
and wild-type enzyme, but longer abortive RNAs were produced at greater or lesser amounts by 
the mutant enzymes depending on promoter specificity, RNA length or promoter distance. 
Normally the maximum length of abortive transcripts is 10 nt; however there could be some 
exceptions which produced longer abortive transcripts up to 16 nt. Surprisingly, promoter 
clearance seemed slightly affected by the σ mutants suggesting that the process of abortive RNA 
production might not be tightly associated with that of promoter clearance.  
6.1.2 Application of promoter engineering in gene expression 
 To study gene expression or the effect of a specific promoter on gene expression, a 
reporter gene located downstream of the promoter is normally used. There are various reporter 
genes which have been employed to detect gene expression such as gfp or gusA genes (Alper et 
al., 2006; Leveau and Lindow, 2001; MacLellan et al., 2006; Myronovskyi et al., 2011; Rhodius 
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and Mutalik, 2010). A library of engineered promoters of different strengths has been 
constructed through either mutagenesis of constitutive promoters or chemical synthesis of 
promoter variants (Alper et al., 2006; Jensen and Hammer, 1998; Jørgensen et al., 2004). By 
changing the length and the sequence of the spacer between the -35 and -10 regions, a broad 
range of promoters which differ in strength  has been studied in Lactococcus lactis. Randomizing 
the spacers resulted in a remarkable change in activities up to 400-fold (Jensen and Hammer, 
1998). It was also emphasized that the context in which the consensus sequences are embedded 
significantly influences the promoter strength. In a subsequent study, this strategy has been 
employed to obtain the expression of the pyrG gene encoding CTP synthase at different levels 
and its effect on the growth rate and nucleotide pool size (Jørgensen et al., 2004). Another library 
of nearly 200 promoters was also obtained using error-prone PCR to examine gene expression in 
E. coli via using gfp as a reporter gene (Alper et al., 2006). These promoter strengths were also 
assessed by testing the effect of the expression of the ppc gene encoding phosphoenol pyruvate 
(PEP) carboxylase on growth yield and encoding deoxy-xylulose-P synthase on lycopene 
production. It was suggested that the optimization of gene expression could depend on the 
genetic background of the strain. 
 The objective of this strategy is to replace a single inducible promoter with a broad range 
of native promoters of different strengths. Although inducible promoters allow for tuning gene 
expression at various levels of inducers, using this system might limit practical applications at an 
industrial scale due to expensive inducer costs, heterogeneities in cellular response and difficulty 
in optimizing inducer concentration and inducing time as well as maintaining a steady expression 
level of the enzyme (Alper et al., 2006; Jensen and Hammer, 1998). Therefore, we would like to 
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employ a wide range of constitutive promoters in strength to examine their effect on polymer 
production. 
6.2 Results and discussion 
6.2.1 Construction of plasmids with promoters of different strengths 
 A range of promoters of different strengths (6 out of 12 native promoters) based on a 
previous study (MacLellan et al., 2006) was chosen for further investigation. These promoter 
sequences (Table 2) were synthesized in the form of extended primers that were annealed to 
create double-strand DNAs. The backbone plasmid, pTH1227a, is a derivative of pTH1227 that 
had the XbaI site removed by being digested, blunted and self-ligated as shown in Figure 6.1. 
Promoter P0 was designed to contain XbaI site next to HindIII site, and cloned into pTH1227a at 
the HindIII and XhoI sites, creating pTH1227b. Next, the synthesized fragment which contains 
two engineered genes were inserted into the pTH1227b at the XhoI and PstI sites. The rest of the 
promoter set containing BglII for post-cloning confirmation was cloned into XbaI and XhoI, 
replacing promoter P0. As a result, we have constructed 6 different versions of the pTAM 
plasmid carrying different promoters of varying strengths. 
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Figure 6.1 Construction of plasmids with promoters of different strengths. In the last step, P0 was replaced with Pi which is one of five 
promoters (P1, P2, P3, P4 and P5).
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6.2.2 GusA activities obtained by expressing gusA gene under a set of constitutive 
promoters of different strengths in the presence of synthesized genes 
 GusA activity assays were performed to examine the level of gene expression according 
to each specific promoter that was used. As shown in Figure 6.2, a wide range of GusA activity 
was obtained indicating that different levels of gene expression were successfully achieved. 
Also, in some cases the level of gene expression was even lower than the background level of 
gene expression obtained by using the inducible promoter. However, the transcriptional levels of 
some promoters in our study were completely contradictory to previously reported values. For 
example, we found that the pTAM7 plasmid carrying the ropB1 promoter exhibited the highest 
levels of expression, while MacLellan et al (MacLellan et al., 2006) had previously demonstrated 
that this same promoter had the lowest level of expression among the same set of promoters. 
Another promoter that strongly disagreed with MacLellan et al in terms of gene expression level 
was the Smc1378 gene promoter in the pTAM2 plasmid. In the previous study, expression was 
the highest of all of the promoters, but we found that the expression was relatively low compared 
to other promoters in the same set. This finding raised concerns about potential context effects on 
gene expression. It could be due to plasmid backbone, inserted gene sequence, the reporter gene 
employed or the cultivation condition. In a previous study, the relative promoter activity has 
been proved to remain unchanged across different cultivation conditions (Keren et al., 2013). 
The activities of roughly 900 S. cerevisiae and 1800 E. coli promoters are taken into 
consideration, and their gene expressions changed among different cultivation conditions by a 
constant factor. In other words, they mostly behaved alike and maintained their relative activities 
levels across different cultivation conditions. Therefore, the cultivation condition could be ruled 
out as a possible cause. Among the remaining potential causes, we postulated that inserted gene 
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sequence most probably caused the irrelative change in gene expression of some promoters. 
Therefore, we removed this inserted sequence from the plasmid construct and compared the 
GusA activity of the construct with and without these inserted genes.  
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Figure 6.2 GusA specific activity of S.meliloti phaC mutant SmUW499 harbouring either the 
parental plasmid (pTH1227) or different pTAM derivatives (pTAM, pTAM2 -> pTAM7). 
pTH1227: empty plasmid, inducible pTac promoter; pTAM: inducible pTac promoter + insert 
genes; pTAM2: smc1378 gene promoter + insert genes; pTAM3: rpmJ gene promoter + insert 
genes; pTAM4: rpmE gene promoter + insert genes; pTAM5: secE gene promoter + insert genes; 
pTAM6: rpoD gene promoter + insert genes; pTAM7: ropB1 gene promoter + insert genes 
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6.2.3 GusA activities obtained by expressing gusA gene under a set of constitutive 
promoters of different strengths in the absence of synthesized genes 
 To further investigate the effect of the synthesized genes on the promoter strength, we 
chose three plasmids, pTAM2, pTAM6 and pTAM7, which carried the smc1378, rpoD and 
ropB1 promoters, respectively. Since the expression from the smc1378 and ropB1 promoters was 
in strong disagreement with the previous study of MacLellan et al. on expression of these 
reporter genes while rpoD gene maintained the weakest activity in both our study and the 
previous study, we thought that it would be interesting to examine the expression of the reporter 
gene under these promoters in the absence of the intervening synthesized genes. Therefore, the 
fragment containing the synthesized genes was removed by XbaI and PstI digestion followed by 
self-ligation, named pTAM2nopctPhaC, pTAM6nopctPhaC and pTAM7nopctPhaC. 
Surprisingly, removal of synthesized genes recovered the original promoter activities which were 
reported in by MacLellan et al. for strains which have genes expressed under the smc1378 and 
ropB1 promoters (Figure 6.3). The rpoD promoter still maintained the low activity which was 
observed with and without the inserted genes. This suggested that the downstream sequence 
probably influenced the transcription process. Other work has shown that the downstream region 
can have a strong influence on the efficiency of the escape process of RNA polymerase because 
release of the σ subunit only occurs after the polymerase has transcribed 8-11 nucleotides (Chan 
and Gross, 2001; Hernandez et al., 1996). This region was earlier reported by Bujard and co-
workers (Kammerer et al., 1986). They found that the down-stream sequence could change the 
promoter strength in vivo more than 10-fold. The reason is that RNA polymerase covers a larger 
region than 35 bp (up to 70 bp); hence, its activity also depends on the flanking regions which 
could be up-stream or down-stream regions. It was known that this region was involved in 
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promoter escape; however, the mechanism of this process was not understood. By further study 
of the anti initial transcription sequence (ITS) which was discovered earlier to have an effect on 
promoter strength, it was found that the function of the anti ITS did not depend on either the 
stability of RNA:DNA bond or the interaction with core RNA polymerase. It appeared that the 
function of anti ITS was related to the σ subunit. As a result, the interactions between them could 
influence the promoter escape. In other studies, it was also observed that characterized promoters 
often showed variable activities depending on the genetic locus or gene transcribed (Alper et al., 
2006; Hammer et al., 2006; Jensen and Hammer, 1998; Kelly et al., 2009; Martin et al., 2009). A 
library of variable-strength, constitutive promoters was designed and constructed in bacteria 
(Davis et al., 2011). The length of these promoters is 160 bp including extended sequences at 
both the 5'- and 3'-ends, so-called insulation sequences. Their promoter strengths were shown to 
maintain constant relative levels and be independent of genetic contexts. From the above 
evidence, we reason to suspect that the initial sequence of roughly 20 bp in the synthesized gene 
fragment may have had some effect on promoter strengths. Since the promoter activities were 
indirectly assessed through the expression of gusA reporter gene, there is no clear evidence to 
prove that these observations happened at the transcriptional level, not translational level. 
Therefore, we continued to investigate the abundance of RNA transcripts of pct and gusA genes 
in the pTAM2 and pTAM7 plasmids to verify these observations occurring at the transcriptional 
level. 
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Figure 6.3 Comparison of activity of gusA gene (left axis) and gfp gene (right axis). Dark bars: S. 
meliloti strains SmUW499 carrying one of three plasmids pTAM2, pTAM6 and pTAM7 which 
are composed of smc1378, rpoD, ropB1 gene promoters, respectively, and synthesized genes 
were measured the activity of gusA gene. Light bars: S. meliloti strains SmUW499 carrying one 
of three derivative plasmids pTAM2, pTAM6 and pTAM7 which are composed only smc1378, 
rpoD, ropB1 gene promoters, respectively, were measured the activity of gusA gene. Triangle 
dots: the activity of gfp gene which were expressed under the corresponding promoter have been 
reported in a previous study (MacLellan et al., 2006). Error bars represent the range of the mean. 
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6.2.4 Analysis of transcript abundance of gusA and pct genes using dot blot 
  From the above results, the presence of synthesized genes that changed genetic context 
has shown the effect on the activity level of some promoters which were indirectly assessed by 
measuring gusA activity of the reporter gene. As shown in Figure 6.4 and Figure 6.5, the 
abundance of gusA transcripts corresponded with the GusA activity, suggesting that the presence 
of synthesized genes caused the decrease and increase of gusA transcripts for pTAM2 and 
pTAM7 plasmids, respectively. The abundance of pct transcripts was also investigated and 
compared to that of gusA transcripts on the plasmids carrying the synthesized genes (see in 
Appendix D). As our expectation, the abundance of pct transcripts is similar to that of gusA 
transcripts since they are transcriptionally fused. These results support the hypothesis that the 
downstream sequence influenced on the transcription process which led to the change in the 
abundance of transcripts and enzyme activity as a consequence. However, which sequence of the 
downstream region and how far is it from TSS are still not identified. As mentioned earlier, the 
first 20 amino acids following the TSS might play an important role in either facilitating or 
impeding the transcriptional process. Therefore, it would be interesting to further investigate 
these sequences in the future. 
 There have been a number of studies focusing on the effect of the -10 and -35 regions on 
promoter strength. However, only the upstream region before the transcription start site (TSS) 
has been seriously taken into consideration. In our study, it has been shown experimentally that 
this adverse effect exists. In the presence of engineered genes, relative promoter strength is 
different from what was reported. Removal of the insert fragment restored their relative strengths 
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consistently across different reporter genes. We also demonstrated that the change occurred at 
the transcriptional level of both insert fragment and reporter gene. 
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Figure 6.4 Dot blot image of S. meliloti SmUW499 carrying plasmids of different promoters 
using gusA probe. Three left columns represent RNA samples of different amounts (0, 1, 2µg) of 
SmUW255 (SmUW499 (pTH1227)), SmUW564 (SmUW499 (pTAM2nopctphaC)), SmUW567 
(SmUW499 (pTAM7nopctphaC)). The other right three columns represent RNA samples of 
different amounts (0, 1, 2µg) of SmUW256 (SmUW499 (pTAM)), SmUW558 (SmUW499 
(pTAM2)), SmUW563 (SmUW499 (pTAM7)). 
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Figure 6.5 Graph represents the relative intensity on dot blot results as shown in Figure 6.3 
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6.2.5 Polymer production in strains that have synthesized genes expressed under these 
constitutive promoters 
To evaluate the different expression profiles on polymer production, these strains were 
cultivated in define media supplemented with mannitol as a substrate and grown under polymer 
accumulating conditions. As expected, strains carrying pTAM6 and pTAM7, which had the 
weakest and strongest promoter strengths produced the least and most amount of PHB, 
respectively (Figure 6.6). The strains carrying pTAM7 which showed promoter strength similar 
to that of the strain carrying the tac promoter under induction conditions also accumulated a 
similar amount of PHB. Even though other strains showed a range of promoter strengths, they all 
produced rather low amount of polymer. Unfortunately, none of them was able to produce 
copolymer P(3HB-co-LA). Nevertheless, we showed that a range of constitutive promoters could 
be used to regulate the accumulation of polymers.  
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Figure 6.6 P(3HB) production in S.meliloti phaC mutant strains SmUW499 that have synthesized 
genes are expressed under different native promotersP(3HB) production in S.meliloti phaC 
mutant strains SmUW499 that have synthesized genes are expressed under different native 
promoters (pTAM2 -> pTAM7) and inducible promoter (pTAM); the negative control S.meliloti 
SmUW499 strains carrying the empty plasmid pTH1227. Error bars represent the range of the 
mean. 
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6.3 Conclusions 
 In this chapter, we focused on studying the effect of different native promoter strengths 
on polymer production. As shown in the previous chapter, polymer production using an 
inducible promoter was unpredictable and out of beyond our expectation. In addition, the future 
prospective does not support inducer usage in large-scale fermentation. Therefore, we selected a 
range of promoters of different strength that were well-characterized in the literature. However, 
our study did not agree with previous study, in which the relative promoter strengths have varied 
not correspondingly. We found that the inserted gene located close to promoters had a significant 
effect on promoter strengths. We postulated that this effect response may be due to effects on the 
occurred during the releasing process of RNA polymerase from the σ subunit.  
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Chapter 7 Conclusions 
7.1 Research summary 
 We have partially codon-optimized two engineered genes, the pct gene encoding 
propionate CoA-transferase and the phaC gene encoding PhaC synthase and introduced them 
into S. meliloti. They were either integrated into the S. meliloti chromosome and expressed under 
native promoter or introduced into the broad-host range expression vector pTH1227 and 
expressed under the inducible promoter pTac. The pct gene which was originally from 
Clostridium propionicum had an increase of GC content from 40.38% to 53.65% after codon-
optimization. Meanwhile, the phaC gene which was originally from P. putida did not show any 
drastic change of GC content (62.14% compared to initial 58.86%) after codon-optimization 
since P. putida has GC content similar to S. meliloti. In contrast, the overall number of codons 
drastically decreased across both genes (for the pct gene, the number of codons decreased from 
52 to 37; for the phaC gene, the number of codon decreased from 56 to 39). 
 For the chromosome engineered system, the strain exhibited the mucoid, milky white 
phenotype, similar to the phenotype of the wild-type strain. The phaC mutant strain which lacks 
the ability to polymerize 3HB-CoAs showed a distinctly non-mucoid phenotype. To further 
analyze the types of polymers produced, the strain was cultured in defined media supplemented 
with mannitol and subsequently subjected to put through GC-FID analysis process. The 
copolymer P(3HB-co-LA) was found to be produced up to about 15% in the strain. To confirm 
the chemical structure of this compound, we also purified the polymer and analyzed it using both 
GC/MS and NMR. Both experiments gave results consistent with the whole-cell analysis results 
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using GC-FID. The advantage of this system is that genes are permanently maintained in the cell 
without the risk of losing genes and there is no need to add antibiotics which are an added cost. 
 For the plasmid-based engineering system, two codon-optimized genes were placed on a 
broad-host range vector pTH1227 and expressed under an inducible promoter pTac-lacI
q
. In this 
system, we analyzed the polymer produced in both inducing and non-inducing conditions. We 
expected that this system would provide us a tool to finely tune the expression of genes and 
consequently polymer production. The addition of IPTG inducer did increase the expression of 
the synthesized genes which was indirectly assessed by measuring the activity of the gusA 
reporter gene. The pTac-lacI
q
 has been reported in E. coli system, to exhibit no detectable or 
very little leakiness. However, this promoter in S. meliloti appears not to be repressed as 
efficiently as in E. coli. We also examined the Nile red fluorescence . Nile red is known as a non-
specific polymer indicator because the strains producing polymer exhibit fluorescence upon 
binding of polymers to Nile Red. We found that at the background level in the absence of 
inducer, the strains still exhibited fluorescence. More interestingly, the greater the induction with 
IPTG, the less polymer was found to be produced. However this has been reported in previous 
studies in which the enzyme activity did not proportionally correspond to the amount of the 
target products as previously discussed in Chapter 5. It would be necessary to study in-depth 
about the relationship between enzyme kinetics and the mechanism of polymer production. 
Unfortunate, there is no P(3HB-co-LA) accumulated using this system in the phaC mutant 
S.meliloti strain. We also tested this system in different S. meliloti mutant backgrounds (ΔphaZ, 
ΔphaAB, ΔphaAB+Z, ΔphaC+Z); they too, however, were also unable to produce any P(3HB-co-
LA). Once we blocked the pathway that produces 3HB-CoAs which are the direct precursors of 
P(3HB), about 4% PLA was produced in the phaABC mutant harbouring pTAM when cultured 
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in defined media supplemented with lactic acid. This suggests that P(3HB-co-LA) copolymer 
was not produced efficiently in this system because the flow of LA-CoAs is too low to efficiently 
incorporate into growing polymers. Also, the presence of native PhaC synthase appears to 
impede the activity of engineered PhaC synthase resulting in no PLA accumulation; this was 
found in strains that had the 3HB-CoAs pathway blocked but native phaC still active. Since one 
of the advantages of this system is the flexibility, we continued exploring the outcome by 
applying this system in a P. putida background. The pTAM plasmid was introduced into both 
wild-type and phaC mutant strains, while the empty plasmid pTH1227 was also introduced into 
the same strains as controls. We found that only strains harbouring pTAM showed a difference 
phenotype and exhibited the fluorescence on LB supplemented with sodium octanoate and Nile 
Red. Further analysis using GC indicated that these strains were able to produce the novel 
polymer P(3HB-co-LA-co-3HHx-co-3HO) in defined media supplemented with sodium 
octanoate. In other words, the plasmid-based system also worked well in P. putida; and the 
engineered phaC gene was able to accept not only LA-CoAs and 3HB-CoAs but MCL 3HA-
CoAs such as 3HHx-CoAs, 3HO-CoAs as well. We also investigated the polymer production in 
these strains cultured in rich-nutrient media such as LB supplemented with either lactic acid or 
sodium octanoate. The wild-type P. putida KT2440 with the empty plasmid barely accumulated 
polymer in this rich-nutrient media while the strains with the pTAM plasmid (either mutant or 
wild-type background) were able to accumulate polymer. These results suggested that the native 
phaC, not other genes in the pathway, was subject to the regulation induced by the particular 
culture medium that was used. 
 Since the inducible promoter was leaky and not economically cost-effective for an 
industrial scale, we have put efforts into substituting the inducible promoter with native 
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promoters of different strengths. These native promoter strengths have been examined in S. 
meliloti in a previous study by indirect assessment of the fluorescence of the gfp reporter gene. 
However, the promoter strengths assessed by measuring GusA activity in our study did not 
correspond to the results of the previous study. The strongest one that was found in the previous 
study has drastically dropped down the activity while the weakest one became the strongest one 
in our study. The downstream sequence after the TSS presumably gave rise to the observed 
difference in promoter activity since the removal of the insert genes brought back to the initial 
activity of the promoters. So we postulated that this downstream sequence, specifically the 
sequence of insert genes, played an important role in altering the speed of transcriptional process, 
technically the releasing of RNA polymerase from σ unit. In order to prove that this actually 
occurred at the transcriptional level, we carried out a dot blot assay and looked at the abundance 
of gusA and pct transcripts. As we expected, the results were consistent with the enzyme 
activities given by expressing the reporter gene. Therefore, the promoter strengths might be 
different depending on a specific context that they are put into. In addition, although promoter 
activities are characterized mostly based on -10 and -35 regions, we think that these regions are 
inadequate to define promoter strengths. We suggest that a broader range of regions including 
roughly 20 bp before and after this region should be also taken into account.  
7.2 The importance of this study and future perspective 
 Waste treatment and pollution are serious environment-related issues which have adverse 
effect on human health. Petroleum-derived plastics are known to be extremely persistent in the 
environment. Therefore, there is an urgent need to find out alternative materials that can 
substitute these traditional plastics. Biodegradable polymers have emerged as a potential 
candidate because of their easy biodegradability, biocompatibility as well as their wide range of 
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potential applications. PHAs are a good example of biodegradable polymers that have been 
studied extensively and intensively for the past decades because they are naturally produced and 
degraded by bacteria. However, they either do not meet material requirements or cost too much 
for mass production. Therefore, much effort has been put into making PHAs overcome these 
limitations.  
 P(3HB) was one of the first commercialized products developed to the pilot plant stage 
by Imperial Chemical Industries (ICI, England) in the 1980s. However, this business was not 
sustainable since the production cost is high and the properties of this polymer are not superior to 
those of polypropylene. Based on a great deal of intensive research, the blend of 3HB with 3HV 
has been proved to exhibit improved properties compared to those of  P(3HB) only. Therefore, in 
1996, this type of polymer, which had a trade name Biopol, was invested by Monsanto who 
acquired the patents for making the polymer from ICI/Zeneca. However, in 2001, this company 
sold its rights of Biopol to Metabolix, an American company, which was planning to broaden its 
range of PHA products. As of 2004, all of the Monsanto's fermenters which were used for 
P(3HB) production were closed down. Meanwhile, Metabolix, an innovation-driven bioscience 
and engineering company founded in 1992, is still continuing to develop and commercialize 
PHA biopolymers to the market via fermentation using renewable carbon based feedstocks. 
According to the statement on Metabolix company, the growing demand for conventional 
plastics is 3-5% annually which is approximately 40 million metric tons. This raised more 
concerns about the scale-up accumulation of plastic waste in the environment. It was estimated 
that approximately 20% is the annual growth rate of increasing demand for biobased and 
biodegradable polymer. In addition to Metabolix, other top companies involving in the PHA 
business are Meredian Inc. (U.S.), Biomer (Germany), Tianjin GreenBio Materials Co. Ltd 
141 
 
(China), and Shenzhen Ecomann Technology Co. Ltd (China). According to the report 
"Polyhydroxyalkanoate (PHA) Market, By Application (Packaging, Food Services, Bio-medical, 
Agriculture) & Raw Material - Global Tends & Forecasts to 2018", they forecasted that PHA 
market consumption will reach 34,000 MT by 2018. 
 It was easily seen that basic research has tremendously contributed to enhance both the 
properties of the polymer as well as the productivity so that these polymers can eventually join 
the market, and serve society. As reviewed in the Chapter 1, P(3HB) was first investigated in a 
number of different bacteria. Even though this type of polymer is naturally produced in many 
bacteria, scientists still employ molecular tools, such as gene knock-out or heterologous 
expression, to engineer these strains so that it can produce the polymer even better with a higher 
yield. Based on these research efforts, it eventually came out into the market when ICI first 
launched it in the 1980s. However, P(3HB) is too brittle to compete with conventional plastics, 
resulting in endless efforts to search for alternative materials, such as P(3HB-co-3HV), MCL 
PHA, (SCL-co-MCL) PHA, PLA, P(3HB-co-LA) and so on. P(3HB-co-3HV) with a trade name 
Biopol was the second commercialized products made by Monsanto company. Therefore, basic 
research plays a critical role in gaining insights into different types of polymers and their 
properties to search for the best candidate as well as enhance the productivity to reduce the 
production cost. Because of their wide range of applications, the increase in industrial investment 
into PHA production is going to happen in the not too distant future.  
 With the same goal, our study has made advances in the exploitation of bacterial systems 
as efficient platforms for novel polymer production. We have shown that we can achieve a wide 
range of different types of polymers produced in S. meliloti and P. putida such as P(3HB), PLA, 
P(3HB-co-LA) and P(3HB-co-LA-co-3HHx-co-3HO). However, the production has not yet met 
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industrial requirements in terms of productivity and cost. Further studies are required to enhance 
the productivity so that these biopolymers may eventually be commercialized and mass-
produced. 
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 Appendix  
A. Media recipes and reagent solutions 
A.1 Media recipes 
- Trypton Yeast (TY)/ 1L 
Tryptone 5g 
Yeast Extract 3g 
CaCl2.2H2O 0.44g 
- Luria-Bertani (LB)/ 1L 
NaCl 5g 
Tryptone 10g 
Yeast Extract 5g 
- M9 (20X stock)/ 1L 
Na2HPO4 11.6g 
KH2PO4 6g 
NaCl 1g 
NH4Cl 2g 
- 0.5E2/ 1L 
NaNH4HPO4.4H2O 1.75g 
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K2HPO4.3H20 3.75g 
KH2PO4 1.85g 
MgSO4.7H2O (stock 100mM) 10ml 
TMS 1ml 
Trace metal solution (TMS): 2.78g FeSO4.7H2O, 1.98g MnCl2.4H2O, 2.81g CoSO4.7H2O, 1.47g 
CaCl2.2H2O, 0.17g CuCl2.2H2O, 0.29g ZnSO4.7H2O. in 1N HCl. 
- Yeast Extract Mannitol (YEM)/ 1L 
Yeast Extract  0.5g 
K2HPO4  1g 
NaCl  0.1g 
MgSO4 0.2g 
CaCl2 0.5g 
FeCl3 6 mL of FeCl3 stock (0.67 g/L) 
A.2 Reagent solution 
- Reagents for plasmid miniprep/ gel purification 
Solution 1: 50mM Tris, 10mM EDTA, 100 µg ml RNAse,  pH8 
Solution 2: 1% SDS, 0.2 M NaOH 
Solution 3: 4 M guanidine, 0.9M potassium acetate, pH4.8 
Elution: 2mM Tris 
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Binding buffer : 5.3M GUITC, 15mM EDTA, 120mM MFS,  
- Reagent for enzyme assay 
Sonication buffer 20mM TrisHcl, 1mM MgCl2, 10% glycerol, 10mM β-mercapethanol 
 
B. DNA sequence of synthesized genes 
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C. Increasing the flow toward LA monomer fraction 
C.1 Introduction 
 This strategy is to aim at increasing the flow toward producing more precursors of lactic 
acid monomesr derived from sugar. Two genes encoding the lactate dehydrogenase and the 
acetyl-CoA synthetase were selected and introduced into the engineered S. meliloti system in this 
study. 
  Lactate dehydrogenase links metabolites from the glycolysis pathway to the lactyl-CoA 
production by converting pyruvate into D-lactate as shown in Figure 3.1. Two genes encoding 
the lactate dehydrogenase were chosen to examine originated from E. coli and S. fredii strains. 
This NADH-linked enzyme encoded by the ldhA gene from E. coli strain has been well-
characterised in previous studies (Bunch et al., 1997; Mat-jan et al., 1989). This gene was highly 
homologous to genes for other D-lactate-specific dehydrogenase but not to those for the L-
lactate-specific enzymes. In contrast, the glcD gene (NGR_c2063) from S. fredii has not been 
studied well in the literature.  
 The acetyl CoA synthetase can metabolize acetate to acetyl CoA to supply the pool of 
CoA for precursors of polymer production. Two genes encoding the acetyl CoA synthetase were 
chosen to examine originated from E. coli and S. fredii strains. The acs gene from E. coli has 
been studied quite well previously while the acs gene from S. fredii strain has not been 
characterized (Barak and Abouhamad, 1998; Kumari et al., 2000).  
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C.2 Results and discussion 
C.2.1 Construction of plasmids carrying genes from either E. coli or S. meliloti 
 The ldhA gene from E. coli strain was digested and introduced into the plasmid pSRKGm 
at NdeI and SacI sites to generate the new plasmid pSRKldhA. Then, the acs gene from E. coli 
strain was digested and introduced into the plasmid pSRKldhA at SacI and SpeI sites to generate 
the resulting plasmid pSRKldhAacs as shown in Figure C.1.  
 The glcD gene from S. fredii strain was digested and introduced into the plasmid 
pSRKGm at NdeI and SpeI sites to generate the new plasmid pSRKglcD. Then, the acs gene 
from S. fredii strain was digested and introduced into the plasmid pSRKglcD at SpeI and HindIII 
sites to generate the resulting plasmid pSRKglcDacs as shown in Figure C.2.  
 These resulting plasmids were then introduced into engineered strains, SmUW254 and 
SmUW256 to examine the enzyme activities of the lactate dehydrogenases. In addition, in order 
to investigate the activity of the acetyl-CoA synthetase by observing the complementation of the 
acs mutant S. meliloti strain harbouring one of two constructed plasmids (pSRKldhAacs or 
pSRKglcDacs). 
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Figure C.1 Construction of expression plasmid pSRKacsldhA. Genes including acs and ldhA 
from E. coli were introduced into pSRKGm as outlined in the above figure.  
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Figure C.2 Construction of expression plasmid pSRKacsglcD. Genes including acs and glcD 
from S. fredii were introduced into pSRKGm as outlined in the above figure. 
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C.2.2 Measurement of lactate dehydrogenase activity 
 Introducing the pSRKacsldhA  and pSRKacsglcD into engineered strains (SmUW254 or 
SmUW256) by conjugation. Then enzyme assays were performed to determine the activity of the 
lactate dehydrogenase.  
 For the chromosome-engineered strain SmUW254, the assays were performed with the 
strains equipped with the lactate dehydrogenase gene from either E. coli or S. meliloti under 
inducing and non-inducing conditions. Only the lactate dehydrogenase gene from S. fredii 
showed the increase in lactate dehydrogenase activity as shown in Figure C.3. It could be that the 
gene from E. coli was unable to be expressed in S. meliloti because the codon usage in E. coli is 
different from that in S. meliloti. 
 For the plasmid-based engineered strain SmUW256, the assays were also performed with 
the strains equipped with the lactate dehydrogenase gene from either E. coli or S. meliloti under 
inducing and non-inducing conditions. However, the enzyme activity was unable to detected 
regardless of which lactate dehygrogenase gene was used. The reason still remained unknown; 
however, using two inducible plasmids in the same strain might have some drawbacks for 
expression system. 
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Figure C.3 Measurement of lactate dehydrogenase activity when expressing ldhA gene from E. 
coli and glcD gene from S. fredii in S. meliloti SmUW254 background in both inducing and non-
inducing conditions.  
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Figure C.4 Measurement of lactate dehydrogenase activity when expressing ldhA gene from E. 
coli and glcD gene from S. fredii in S. meliloti SmUW256 background in both inducing and non-
inducing conditions.  
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C.2.3 Measurement of acetyl-CoA synthetase activity 
To investigate the enzyme activity of acetyl-CoA synthetase, genes from E. coli and S. 
fredii were introduced and expressed in acs mutant S. meliloti strain Rm11382. Then, the growth 
curve was constructed by recording the absorbance at 600nm over time (Figure C.5). The wild-
type strain Rm1021 was used as a positive control; the acs mutant S. meliloti harbouring the 
empty plasmid was used as a negative control. Only the strain carrying the gene from E. coli was 
able to grow in M9 media supplemented. The growth of Rm is quite slow compared to that of the 
wild-type strain.  
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Figure C.5 Growth curve of different strains on M9 supplemented with acetate as sole carbon 
source. 
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D. Other data 
 
Figure D.1 Dot blot image of S. meliloti SmUW499 carrying plasmids of different promoters 
using pct probe. Three left columns represent RNA samples of different amounts (0, 1, 2µg) of 
SmUW255 (SmUW499 (pTH1227)), SmUW564 (SmUW499 (pTAM2noinsert)), SmUW567 
(SmUW499 (pTAM7noinsert)). The other right three columns represent RNA samples of 
different amounts (0, 1, 2µg) of SmUW256 (SmUW499 (pTAM)), SmUW558 (SmUW499 
(pTAM2)), SmUW563 (SmUW499 (pTAM7)). 
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